好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

2006 Annual Meeting | Poster Session 04

Wednesday 04/05/06
03:00 PM - 07:00 PM Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Scientific Poster Session
Movement Disorders, Cerebrovascular Disease and Interventional Neurology, Critical Care/Emergency Neurology/Trauma, Headache and Pain, Behavioral Neurology, Aging and Dementia, MS and Related Diseases, Peripheral Nerve, Neuroepidemiology/Health Services and Outcomes Research, Anterior Horn
No CME available
Event Timeline
03:00 PM - 07:00 PM Abstract 001 - A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial To Assess the Efficacy and Safety of Lacosamide in Subjects with Painful Distal Diabetic Neuropathy
03:00 PM - 07:00 PM Abstract 002 - Spinal Cord Stimulation in Treatment of Chronic Benign Pain: Challenges in Treatment Planning and Present Status, a 22-Year Experience
03:00 PM - 07:00 PM Abstract 003 - Exploration of Relationships between Population Characteristics and Response to Pregabalin in Five Randomized, Placebo-Controlled Trials in Postherpetic Neuralgia
03:00 PM - 07:00 PM Abstract 004 - Pregabalin for Painful Diabetic Peripheral Neuropathy and Postherpetic Neuralgia: Onset and Duration of Analgesia in Combined Analyses of Clinical Studies
03:00 PM - 07:00 PM Abstract 005 - Colinesterase Inhibitors for Trigeminal Pain Control: Randomized Controlled Trial Involving Placebo, Rivastigmine, Donezepil, Galantamine and Neostigmine
03:00 PM - 07:00 PM Abstract 006 - Low Temperature Radiofrequency Neurotomy (LTRF) for the Treatment of Cervicogenic Headache: A Safer Alternative
03:00 PM - 07:00 PM Abstract 007 - Asymmetric Upper Extremity Pain Syndrome: Clinical Aspects and Underlying Autonomic Dysfunction
03:00 PM - 07:00 PM Abstract 008 - The Safety and Efficacy of Lacosamide in the Long-Term Treatment of Diabetic Neuropathic Pain
03:00 PM - 07:00 PM Abstract 009 - Duloxetine in the Management of Diabetic Peripheral Neuropathic Pain (DPNP): Temporal Profile of Treatment Emergent Adverse Events
03:00 PM - 07:00 PM Abstract 010 - Pregabalin Rapidly and Significantly Improves Sleep Disturbances in Chronic Pain Syndromes and Is Associated with Sleep Improvements in Healthy Volunteers
03:00 PM - 07:00 PM Abstract 011 - Dopaminergic Modulation of Semantic Priming in Parkinson's Disease
03:00 PM - 07:00 PM Abstract 012 - Impaired Linguistic Processing of Quantifiers in Corticobasal Degeneration
03:00 PM - 07:00 PM Abstract 013 - Implicit Learning of a Novel Semantic Category in Semantic Dementia and Progressive Non-Fluent Aphasia
03:00 PM - 07:00 PM Abstract 014 - Primary Progressive Aphasia in a Bilingual Woman
03:00 PM - 07:00 PM Abstract 015 - Focal Anatomical Correlates of Three Language Tasks in Neurodegenerative Diseases
03:00 PM - 07:00 PM Abstract 016 - Category- Specific Semantic Knowledge in Alzheimer's Disease and Semantic Dementia
03:00 PM - 07:00 PM Abstract 017 - Semantic Naming Errors in Semantic Dementia
03:00 PM - 07:00 PM Abstract 018 - Judging Category Boundaries: Evidence from Semantic Dementia
03:00 PM - 07:00 PM Abstract 019 - Intact Word Structure Alongside Impaired Word Meanings in Two Individuals with Semantic Dementia
03:00 PM - 07:00 PM Abstract 020 - Sentences with a Temporary Structural Ambiguity and High Working Memory Load Recruit Additional Neural Resources for Disambiguation: Evidence from fMRI and Neural Network Modeling
03:00 PM - 07:00 PM Abstract 021 - The Neurobiology of Trust
03:00 PM - 07:00 PM Abstract 022 - Correlation of Improvements in Quality of Life and Relationships with Reduction in CNS-LS Scores in Pseudobulbar Affect Patients Treated with AVP-923
03:00 PM - 07:00 PM Abstract 023 - Pathologic Laughter in Levodopa Treatment: A Biphasic Phenomenon?
03:00 PM - 07:00 PM Abstract 024 - Social Cognition in Frontotemporal Dementia
03:00 PM - 07:00 PM Abstract 025 - Ratings of "Mental Rigidity" and Striatal Dopamine Transporter Activity in Patients with Parkinson's Disease
03:00 PM - 07:00 PM Abstract 026 - Gambling in Parkinson's Disease: Pathologic Personnality or Iatrogeny?
03:00 PM - 07:00 PM Abstract 027 - Social Cognition in Patients with Epilepsy after Anterior Temporal Lobe Resections
03:00 PM - 07:00 PM Abstract 028 - Induced Frequency Response to Single Pulse Electrical Stimulation
03:00 PM - 07:00 PM Abstract 029 - Neurocognition in Short-Term Abstinent Alcoholics: Preliminary Data on the Effects of Concurrent Chronic Cigarette Smoking
03:00 PM - 07:00 PM Abstract 030 - Abnormal Musical Pacemaker in a Patient with Musical Hallucinations
03:00 PM - 07:00 PM Abstract 031 - Prevalence and Treatment of Non-Motor Symptoms in Parkinson's Disease
03:00 PM - 07:00 PM Abstract 032 - Laterality, Location, Type and Severity of Motor Dysfunction May Predict Cognitive Decline in Parkinson's Disease
03:00 PM - 07:00 PM Abstract 033 - Cognitive Complaint in Parkinson's Disease: Its Relation with Objective Assessment of Cognitive Function
03:00 PM - 07:00 PM Abstract 034 - Characteristics of Sleep and Predictors of Daytime Sleepiness in a Community-Based Sample of PD Patients
03:00 PM - 07:00 PM Abstract 035 - A Controlled Study of Limbic Dysfunction in Non-Demented Parkinson's Disease (PD-ND)
03:00 PM - 07:00 PM Abstract 036 - A Prospective Survey of Punding in an Ambulatory Parkinson Disease Population
03:00 PM - 07:00 PM Abstract 037 - Depression in Parkinson's Disease Tracks Cognitive Decline Globally
03:00 PM - 07:00 PM Abstract 038 - Failure To Recognize Depression in Parkinson's Disease on the UPDRS
03:00 PM - 07:00 PM Abstract 039 - Apathy: Its Characteristics in Parkinson's Disease
03:00 PM - 07:00 PM Abstract 040 - Quantitative Electroencephalography Can Distinguish between Parkinson's Disease Patient Groups Classified According to Clinical Cognitive Dysfunction and Neuropsychometric Performance
03:00 PM - 07:00 PM Abstract 041 - Long-Term Efficacy of Subthalamic Nucleus Stimulation in Advanced Parkinson's Disease: Five-Year Follow-Up
03:00 PM - 07:00 PM Abstract 042 - Evolutive Profile of Off Motor Score under STN Stimulation
03:00 PM - 07:00 PM Abstract 043 - Atlas-Based Localization of Active DBS Contacts in Parkinsonian Patients with Best Clinical Outcome at the Salp[ecirc]tri[egrave]re Hospital, Paris
03:00 PM - 07:00 PM Abstract 044 - Relation of Postoperative MRI Electrode Location with Optimal Clinical Outcome in Parkinson's Disease (PD) Patients Undergoing Subthalamic Nucleus (STN) Deep Brain Stimulation (DBS)
03:00 PM - 07:00 PM Abstract 045 - The Audiospinal Reaction in Parkinsonian Patients: Effects of Subthalamic Deep Brain Stimulation and Correlations with Dopa-Resistant Freezing of Gait
03:00 PM - 07:00 PM Abstract 046 - Longitudinal Assessment of Quality of Life among Persons Receiving Deep Brain Stimulation for the Treatment of Parkinson's Disease: Patient and Caregiver Perspectives
03:00 PM - 07:00 PM Abstract 047 - Quality of Life and Psychological Consequences in Patients and Spouses 6 Months after Subthalamic Stimulation for Parkinson's Disease
03:00 PM - 07:00 PM Abstract 048 - Subthalamic DBS for the Treatment of Off-Medication Dyskinesias after Fetal Tissue Transplantion in PD
03:00 PM - 07:00 PM Abstract 049 - Dissociable Subthalamic Deep Brain Stimulation (DBS) Effects on Declarative and Non-Declarative Memory in Parkinson Disease
03:00 PM - 07:00 PM Abstract 050 - Frontostriatal Cognitive Functioning 6-Months Following Bilateral Subthalamic Nucleus Deep Brain Stimulation
03:00 PM - 07:00 PM Abstract 051 - Dietary Risk Factors for Parkinson's Disease (PD) in Twins
03:00 PM - 07:00 PM Abstract 052 - Prevalence of Parkinson's Disease in Farming vs. Non-Farming Counties in the US VHA Population
03:00 PM - 07:00 PM Abstract 053 - The Effect of Elevated Blood Pressure on the Prevalence of Parkinson's Disease in a Rural Population in China: A Case-Control Study
03:00 PM - 07:00 PM Abstract 054 - Hypertension, Hypercholesterolemia, Diabetes and Risk of Parkinson's Disease
03:00 PM - 07:00 PM Abstract 055 - Lower Caffeine Consumption Is Associated with Reduced Olfactory Function in First Degree Relatives of Patients with Parkinson's Disease: A Pilot Study
03:00 PM - 07:00 PM Abstract 056 - Prospective Study of Smoking and Decline in Cognitive Function in Parkinson's Disease
03:00 PM - 07:00 PM Abstract 058 - Increased Insular Lewy Body Density in Parkinson's Disease Patients with Orthostatic Hypotension
03:00 PM - 07:00 PM Abstract 059 - Delaying Gastric Emptying Time and Gastrointestinal Symptoms in Patients with Parkinson's Disease
03:00 PM - 07:00 PM Abstract 060 - Tegaserod in Parkinson Disease (PD)-Associated Constipation
03:00 PM - 07:00 PM Abstract 061 - Midlife Adiposity and Risk of Alzheimer's Disease Two Decades Later
03:00 PM - 07:00 PM Abstract 062 - Exceptional Parental Longevity Protects Against Dementia
03:00 PM - 07:00 PM Abstract 063 - The Mayo Clinic Cohort Study of Oophorectomy and Aging: Results for Dementia and Cognitive Impairment
03:00 PM - 07:00 PM Abstract 064 - Cognitive Decline Is Associated with Sleep Disturbance in Older Community-Dwelling Women
03:00 PM - 07:00 PM Abstract 065 - Is Cognitive Decline Associated with Depression? A Prospective Epidemiologic Study
03:00 PM - 07:00 PM Abstract 066 - Diabetes and Parkinsonian Signs in Older Persons without Dementia
03:00 PM - 07:00 PM Abstract 067 - Better Cognitive Performance in Elderly Taking Vitamins E and C in Combination with NSAIDs: The Cache County Study
03:00 PM - 07:00 PM Abstract 068 - Prevalence, Mortality and Predictive Factors on Survival of Dementia in Shanghai, China
03:00 PM - 07:00 PM Abstract 069 - Executive Function and 18-Year All-Cause Mortality in Elderly Men: Confirmation in Two Independent Samples
03:00 PM - 07:00 PM Abstract 070 - Prevalence and Predictors of Potentially Inappropriate Medication Use among Patients with Cognitive Impairment
03:00 PM - 07:00 PM Abstract 071 - Weight Loss in Alzheimer's Disease Precedes Diagnosis
03:00 PM - 07:00 PM Abstract 072 - African American and Latino Alzheimer's Disease Patients Have Longer Survival Than White Alzheimer's Disease Patients: Data from the National Alzheimer's Coordinating Center Datasets
03:00 PM - 07:00 PM Abstract 073 - 好色先生 and Neuropathological Alzheimer's Disease, with and without Dementia
03:00 PM - 07:00 PM Abstract 074 - Evidence for Preconditioning in Healthy Brain Aging among the Oldest Old
03:00 PM - 07:00 PM Abstract 075 - Association between Depressive Symptoms, Major Depressive Episode and Cognitive Deficits in the Elderly. The 3C Study
03:00 PM - 07:00 PM Abstract 076 - 好色先生 Delays Accelerated Decline in Memory in Persons Who Develop Dementia: Evidence for Cognitive Reserve
03:00 PM - 07:00 PM Abstract 077 - Vascular Markers and Clinical Dementia: Results from the Einstein Aging Study
03:00 PM - 07:00 PM Abstract 078 - Association of Dementia with Parkinsonian Signs in the Elderly General Population in Central Spain
03:00 PM - 07:00 PM Abstract 079 - Olfactory Impairment Is Associated with Low Scores on a Measure of Semantic Interference Eight Years Later
03:00 PM - 07:00 PM Abstract 080 - Behavioral Symptoms Predict Institutionalization, Faster Cognitive and Faster Functional Decline in Alzheimer's Disease (AD)
03:00 PM - 07:00 PM Abstract 081 - Incidence of Cervical Artery Dissection in a Community: Olmsted County, Minnesota 1987-2003
03:00 PM - 07:00 PM Abstract 082 - Classical Risk Factors for Ischemic Stroke in a Colombian Population
03:00 PM - 07:00 PM Abstract 083 - Stroke in Young Patients: Comparison of Two Populations According to Age
03:00 PM - 07:00 PM Abstract 084 - An Unique Pilote Study in France: 20-Year Trends of Prevalence of Blood Hypertension and Its Treatment before Stroke Onset, from the Dijon Stroke Registry
03:00 PM - 07:00 PM Abstract 085 - Physical Activity Levels for Women: Comparison of Two New York City Populations
03:00 PM - 07:00 PM Abstract 086 - Native Americans, Asian Americans, and Africans Americans Have Disparately High Incidences of Stroke in 2000
03:00 PM - 07:00 PM Abstract 087 - Low HDL-Cholesterol in Persons with Normal LDL-Cholesterol Is Associated with an Increased Risk of Stroke
03:00 PM - 07:00 PM Abstract 088 - Ozone Air Pollution Is Associated to Acute Ischaemic Strokes in Men in Dijon, France. A 10-Year Population-Based Study
03:00 PM - 07:00 PM Abstract 089 - Recurrent Rate and Stroke Pattern of Stroke Patient with Intracranial Artery Disease in Hallym Stroke Registry
03:00 PM - 07:00 PM Abstract 090 - Carotid Plaque Calcification Predicts Incident Stroke, Myocardial Infarction and Vascular Death in the Northern Manhattan Study
03:00 PM - 07:00 PM Abstract 091 - Candidates for Preventive Migraine Therapy in a Community Sample: Results from the American Migraine Prevalence and Prevention (AMPP) Study
03:00 PM - 07:00 PM Abstract 092 - The Impact of Topiramate Prevention on Resource Use among Migraineurs in the Managed Care Setting
03:00 PM - 07:00 PM Abstract 093 - Exploring the Potential for Topiramate To Reduce the Risk of Developing Chronic Daily Headache in a Migraine Population
03:00 PM - 07:00 PM Abstract 094 - Impact of Topiramate for Migraine Prophylaxis on Workplace Productivity: Results from a U.S. Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial
03:00 PM - 07:00 PM Abstract 095 - Greater Occipital Nerve Block for Chronic Daily Headache Using Local Anesthetics with or without Corticosteroids - A Randomized Single-Blind Study
03:00 PM - 07:00 PM Abstract 096 - Cost-Effectiveness of Topiramate for Migraine Prevention: A Managed Care Perspective
03:00 PM - 07:00 PM Abstract 097 - Frovatriptan for the Prevention of Menstrual Migraine Headaches: Results of a 12-Month Open-Label Safety and Tolerability Study
03:00 PM - 07:00 PM Abstract 099 - Effect of Lidocaine Infusion in the Treatment of Refractory Chronic Daily Headache - A Retrospective Study
03:00 PM - 07:00 PM Abstract 100 - Botulinum Toxin Type A in the Treatment of Chronic Migraine without Medication Overuse Headache
03:00 PM - 07:00 PM Abstract 101 - Response to Interferon Beta-1a Treatment in African-American Patients with Multiple Sclerosis
03:00 PM - 07:00 PM Abstract 102 - Risk of Conversion to Clinically Definite Multiple Sclerosis in Acute Partial Transverse Myelitis and Normal Brain MRI
03:00 PM - 07:00 PM Abstract 103 - Decreased Serum Testosterone Levels in Multiple Sclerosis
03:00 PM - 07:00 PM Abstract 104 - Chronic Inflammatory Demyelinating Polyneuropathy and Multiple Sclerosis: Are They Related Diseases?
03:00 PM - 07:00 PM Abstract 105 - Childhood and Adolescent Body Size and Risk of Multiple Sclerosis
03:00 PM - 07:00 PM Abstract 106 - Occurrence of CNS Demyelinating Diseases in Myasthenia Gravis Patients
03:00 PM - 07:00 PM Abstract 107 - Benign or Not so Benign MS
03:00 PM - 07:00 PM Abstract 108 - Relapsing Demyelinating Disease of Both Central and Peripheral Nervous System
03:00 PM - 07:00 PM Abstract 109 - NARCOMS Validation Study
03:00 PM - 07:00 PM Abstract 110 - Acute Demyelinating Encephalomyelitis: Criteria for Evolution through Multiple Sclerosis in a Cohort of 52 Patients
03:00 PM - 07:00 PM Abstract 111 - Racial and Ethnic Differences in Pediatric Multiple Sclerosis
03:00 PM - 07:00 PM Abstract 112 - Depression and Cognitive Impairment in Multiple Sclerosis and Transverse Myelitis
03:00 PM - 07:00 PM Abstract 113 - Familial Multiple Sclerosis in the New York State Multiple Sclerosis Consortium
03:00 PM - 07:00 PM Abstract 114 - Epidemiology of Pediatric Demyelinating Disease at a Tertiary Care Center
03:00 PM - 07:00 PM Abstract 115 - A Case-Control Study of Cancer Risk among MS Patients Treated with Methotrexate
03:00 PM - 07:00 PM Abstract 116 - Rapidly Increasing Incidence of Multiple Sclerosis (MS) over the past 25 Years Renders Crete a High-Risk Geographic Region
03:00 PM - 07:00 PM Abstract 117 - Neurologic Symptoms Suggestive of CNS Demyelinating Disease in the Presence of Normal Imaging and Laboratory Investigations: Long-Term Follow-Up and Development of Multiple Sclerosis
03:00 PM - 07:00 PM Abstract 118 - Does Multiple Sclerosis-Associated Disability Differ between Races?
03:00 PM - 07:00 PM Abstract 119 - Incidence of Seizures and Epilepsy in Multiple Sclerosis: A Meta-Analysis
03:00 PM - 07:00 PM Abstract 120 - Oral Contraceptive Use in Patients with Multiple Sclerosis
03:00 PM - 07:00 PM Abstract 121 - Value of the Oral Glucose Tolerance Test in the Evaluation of Chronic Idiopathic Axonal Polyneuropathy
03:00 PM - 07:00 PM Abstract 122 - The Murine Central and Peripheral Nervous System Transcriptomes: Comparative Gene Expression
03:00 PM - 07:00 PM Abstract 123 - HIV Neuropathy and Glucose Dysmetabolism
03:00 PM - 07:00 PM Abstract 124 - Prospective Study of Diet and Amyotrophic Lateral Sclerosis (ALS) within the CPS II Cohort
03:00 PM - 07:00 PM Abstract 125 - A Cross-Sectional Study of Caregiver Time Use in Amyotrophic Lateral Sclerosis
03:00 PM - 07:00 PM Abstract 126 - Effect of Respiratory Therapist on Noninvasive Ventilation Use in Patients with Amyotrophic Lateral Sclerosis
03:00 PM - 07:00 PM Abstract 127 - Prognosis of Amyotrophic Lateral Sclerosis in Southern Italy: Results from a Population-Based Registry, SLAP (Sclerosi Laterale Amiotrofica-Puglia)
03:00 PM - 07:00 PM Abstract 128 - Riluzole and Amyotrophic Lateral Sclerosis Survival: A Population-Based Study in Southern Italy
03:00 PM - 07:00 PM Abstract 129 - Outcome of Outpatient Neurologic Consultations: Physician Evaluations Compared to Patients' Perceptions
03:00 PM - 07:00 PM Abstract 130 - Cervical Spondylotic Myelopathy: Clinical and MRI Predictors of Outcome after Surgical Intervention
03:00 PM - 07:00 PM Abstract 131 - Comparing Cost-Effectiveness Models for MS Disease-Modifying Agents: Different Inputs and Assumptions Produce Different Conclusions
03:00 PM - 07:00 PM Abstract 132 - Interaction Effects of Non-Heritable Risk Factors for MS in the Italian Study on Twins
03:00 PM - 07:00 PM Abstract 133 - Ethnicity and Socio-Economic Status Do Not Determine Receipt of rt-PA in a Population-Based Study
03:00 PM - 07:00 PM Abstract 134 - Predictors of Delayed Hospital Arrival after Stroke or TIA
03:00 PM - 07:00 PM Abstract 135 - Rural Hospital Capabilities To Participate in Acute Stroke Care
03:00 PM - 07:00 PM Abstract 136 - Trends in Outcomes and Hospitalization Costs of Patients with Myasthenia Gravis Who Are Mechanically Ventilated in United States
03:00 PM - 07:00 PM Abstract 137 - Incidence of Guillain-Barre Syndrome in Buenos Aires, Argentina
03:00 PM - 07:00 PM Abstract 138 - Impact of Long-Term Low-Dose Neurotoxicant Exposure on Neurological and Neuropsychological Test Outcomes
03:00 PM - 07:00 PM Abstract 139 - 好色先生, Physically Demanding Occupations, and the Risk of Parkinson's Disease
03:00 PM - 07:00 PM Abstract 140 - Composite Motor and Olfactory Test Battery Can Be Used as a Screening Instrument for the Diagnosis of Parkinson's Disease in the General Population: A 11C-[beta]-CFT PET Study
03:00 PM - 07:00 PM Abstract 141 - Height as an Indicator of Early Life Events Predicting Parkinson's Disease: A Case-Control Study
03:00 PM - 07:00 PM Abstract 142 - Population-Based Case-Control Study of Reported Hearing Impairment in Essential Tremor
03:00 PM - 07:00 PM Abstract 143 - Alternative Versions of the Orientation-Memory-Concentration Test for Telephone Administration from the Rural Aging and Memory Study
03:00 PM - 07:00 PM Abstract 144 - The Brief Traumatic Brain Injury Screen (BTBIS): Investigating the Validity of a Self-Report Instrument for Detecting Traumatic Brain Injury (TBI) in Troops Returning from Deployment in Afghanistan and Iraq
03:00 PM - 07:00 PM Abstract 145 - Clinician Attitudes toward Quality of Life Measures for Neurological Disorders
03:00 PM - 07:00 PM Abstract 146 - A New Bioassay for the Detection of Neutralizing Antibodies against Interferon-beta in MS Patients: Development, Charcterisation and Validation
03:00 PM - 07:00 PM Abstract 147 - Anti-IFN[beta] Neutralizing Activity Is Not Entirely Mediated by Antibodies: Soluble Type I Interferon Receptor (IFNAR-2) as a New Inhibitory Factor of Interferon in Patients with Multiple Sclerosis
03:00 PM - 07:00 PM Abstract 148 - A 4-Year Study of Anti-Interferon Neutralizing Antibodies in Relapsing-Remitting Multiple Sclerosis Patients Treated with Different Doses of Interferon Beta-1b
03:00 PM - 07:00 PM Abstract 149 - High Levels of Neutralizing Antibodies (NAbs) Against Interferon beta Abolish In Vivo mRNA Expression to Both MxA and TRAIL
03:00 PM - 07:00 PM Abstract 150 - Pharmacodynamics of Interferon-beta Induced mRNA Biomarkers in Multiple Sclerosis Patients with Neutralizing Antibodies
03:00 PM - 07:00 PM Abstract 151 - Validation of Treatment Response Indicators for Multiple Sclerosis: Comparison of a Biological (MxA Protein Level) and a MRI Indicator
03:00 PM - 07:00 PM Abstract 152 - MxA mRNA Levels in Peripheral Blood Mononuclear Cells Serve as Excellent Surrogate Marker for Presence of Neutralizing Antibodies to Interferon in Multiple Sclerosis
03:00 PM - 07:00 PM Abstract 153 - Combination of ELISA and In Vivo MxA Induction Assay Allows Fast and Reliable Detection of Neutralizing Antibodies Against Interferon-beta
03:00 PM - 07:00 PM Abstract 154 - Assesment of INF[beta] Bioavailability in Multiple Sclerosis Treated Patients: MxA mRNA Versus Antibody-Detecting Assays
03:00 PM - 07:00 PM Abstract 155 - The Timed Tandem Walk as a Measure of Mild Impairment in Patients with Multiple Sclerosis
03:00 PM - 07:00 PM Abstract 156 - Relationship of Core Temperature to Physical Activity and Fatigue in MS
03:00 PM - 07:00 PM Abstract 157 - Testing the Executive Functions in Multiple Sclerosis with a Musical Sorting Test
03:00 PM - 07:00 PM Abstract 158 - The Type of MS Treatment Does Not Affect the Prevalence and Severity of Fatigue
03:00 PM - 07:00 PM Abstract 159 - Evolution of Anxiety According to Coping Strategy in Patients with Relapsing-Remitting Multiple Sclerosis Initiating Treatment with IM Interferon beta-1a
03:00 PM - 07:00 PM Abstract 160 - Supervised Resistance Training Improves Muscle Function in Individuals with Multiple Sclerosis
03:00 PM - 07:00 PM Abstract 161 - Validation of the Mindstreams Computerized Cognitive Battery in Multiple Sclerosis
03:00 PM - 07:00 PM Abstract 162 - What Degree of Cognitive Impairment Predicts Poor Quality of Life in Multiple Sclerosis?: The GEDMA Study
03:00 PM - 07:00 PM Abstract 163 - MRI as a Surrogate Outcome Measure of Disability in Multiple Sclerosis: Have We Been Overly Harsh in Our Assessment?
03:00 PM - 07:00 PM Abstract 164 - Fatigue in Multiple Sclerosis and Post-Poliomyelitis Syndrome: Relationship with Disease-Related, Behavioral, and Psychosocial Factors
03:00 PM - 07:00 PM Abstract 165 - Central Fatigue in Patients Affected by Multiple Sclerosis: An Electrophysiological Study by Means of Transcranial Magnetic Stimulation
03:00 PM - 07:00 PM Abstract 166 - When Should Hyperbaric Oxygen Therapy Be Finished for Delayed Symptoms of Carbon Monoxide Poisoning? A Chronological Analyses Using Magnetic Resonance Spectroscopy and Diffusion Tensor Imaging
03:00 PM - 07:00 PM Abstract 167 - Dose-Dependent Neuroprotection of Acute Interferon-[beta]1a after Spinal Cord Injury in Rat
03:00 PM - 07:00 PM Abstract 168 - Novel Method for Quantification of Cerebral Blood Flow (CBF) Asymmetry in Subarachnoid Hemorrhage Patients Using Perfusion-Weighted Computed Tomography (CTP)
03:00 PM - 07:00 PM Abstract 169 - Risk Factors and Clinical Implications of Shivering during Induced Normothermia in Brain-Injured Patients
03:00 PM - 07:00 PM Abstract 170 - Predictors of Favorable Neurologic Outcome 6 Months after Subarachnoid Hemorrhage
03:00 PM - 07:00 PM Abstract 171 - Hemodynamic Response to an Adjunct Arginine Vasopressin Infusion in Refractory Hypertensive, Hypervolemic, Hemodilution Therapy in Subarachnoid Hemorrhage
03:00 PM - 07:00 PM Abstract 173 - Detection of Seizures in ICU Patients Based on Changes in EEG Synchronization Likelihood
03:00 PM - 07:00 PM Abstract 174 - Quantitative Assessment of White Matter Lesions in Diffuse Axonal Injury: Validation of Method and Correlation with Functional Outcome
03:00 PM - 07:00 PM Abstract 176 - Mild Hypothermia Reduces Hemorrhage and Blood Brain Barrier (BBB) Disruption Following Tissue Plasminogen Activator Treatment in Experimental Stroke
03:00 PM - 07:00 PM Abstract 177 - Hypothermia Protects Against Cerebral Ischemia by Suppressing [delta]PKC Activation in a Model of Permanent Middle Cerebral Artery Occlusion
03:00 PM - 07:00 PM Abstract 178 - Adenosine Antagonist Prevent Loss of Striatal Na,K ATPase Activity after Hypoxia-Ischemia
03:00 PM - 07:00 PM Abstract 179 - Hydrogen Sulfide Is the Mediator of Tissue Damage in Cerebral Ischemia
03:00 PM - 07:00 PM Abstract 180 - Progress in Size Estimation of Solid Emboli
03:00 PM - 07:00 PM Abstract 181 - Protective Effect of SUN N8075 on Cerebral Infarction Induced by Middle Cerebral Artery Occlusion and Reperfusion in Cynomolgus Monkeys: PET and Histopathological Studies
03:00 PM - 07:00 PM Abstract 182 - Regeneration in Acute Ischemic Stroke (RAIS): Granulocyte-Colony Stimulating Factor (G-CSF) Treatment in Acute Ischemic Stroke: A Prospective Phase I/II-Study
03:00 PM - 07:00 PM Abstract 183 - Carnitine Treatment Inhibits Increases in Cerebral Carnitine Esters and Glutamate Detected by Mass Spectrometry Following Hypoxia-Ischemia in Newborn Rats
03:00 PM - 07:00 PM Abstract 185 - Focality of ALS: II. 3-D Topography of Motor Neurons in Post Mortem Spinal Cords and the Neuropathologic Gradient of Degeneration
03:00 PM - 07:00 PM Abstract 186 - Quantitative Magnetic Resonance and Histological Analysis of Primary Motor Neuronal Loss in ALS
03:00 PM - 07:00 PM Abstract 187 - A Novel MRI Technique Demonstrates Thinning of Primary Motor Cortex in ALS
03:00 PM - 07:00 PM Abstract 188 - Detection of Upper Motor Neuron Degeneration in Amyotrophic Lateral Sclerosis by Diffusion Tensor Imaging
03:00 PM - 07:00 PM Abstract 189 - Spinal Angiography Reveals Functional Venous Engorgement in Hirayama's Syndrome
03:00 PM - 07:00 PM Abstract 190 - Electrical Impedance Myography as an Outcome Measure in ALS Clinical Trials
03:00 PM - 07:00 PM Abstract 191 - Performance of the ALSFRSr When Administered by Phone to Patients and to Caregivers: Experience from the VA ALS Registry
03:00 PM - 07:00 PM Abstract 192 - Development and Evaluation of the ALSFRS-R as a Self-Administered Tool in Patients with ALS
03:00 PM - 07:00 PM Abstract 193 - Deep Venous Thrombosis (DVT) in Amyotrophic Lateral Sclerosis (ALS)
03:00 PM - 07:00 PM Abstract 194 - Weight Loss Is the Best Marker of Malnutrition in ALS: A Prospective Study
03:00 PM - 07:00 PM Abstract 195 - Effects of Tube-Feeding on Quality of Life and Survival in Amyotrophic Lateral Sclerosis Patients
03:00 PM - 07:00 PM Abstract 197 - Coping Style Is an Important Determinant of Quality of Life in Patients with Amyotrophic Lateral Sclerosis
03:00 PM - 07:00 PM Abstract 198 - Evaluation of Sham Noninvasive Ventilation for Randomized, Controlled Trials in ALS
03:00 PM - 07:00 PM Abstract 199 - Respiratory Rate As Predictor of Hypercapnia and Survival in Amyotrophic Lateral Sclerosis
03:00 PM - 07:00 PM Abstract 200 - Increased Risk of Type II Diabetes Mellitus in Post Polio Syndrome
03:00 PM - 07:00 PM Abstract 201 - Controlled Trial of Modafinil for the Treatment of Fatigue in Post-Polio Syndrome
05:30 PM - 07:00 PM Refreshments
Faculty Disclosures
Helen C. Lin, MD Dr. Lin has received personal compensation for serving as an employee of Genentech. Dr. Lin has stock in Genentech.
Kapil D. Sethi, MD, FRCP (UK), FAAN Dr. Sethi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurocrine.
John T. Kissel, MD, FAAN Dr. Kissel has nothing to disclose.
Matthew P. Wicklund, MD, FAAN Dr. Wicklund has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amicus Therapeutics. Dr. Wicklund has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi-Genzyme. Dr. Wicklund has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta Therapeutics. Dr. Wicklund has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Spark Therapeutics. Dr. Wicklund has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ultragenyx. Dr. Wicklund has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Vertex Pharmaceuticals. The institution of Dr. Wicklund has received research support from Orphazyme. The institution of Dr. Wicklund has received research support from Muscular Dystrophy Association. The institution of Dr. Wicklund has received research support from Coalition to Cure Calpain 3. The institution of Dr. Wicklund has received research support from Sarepta Therapeutics. The institution of Dr. Wicklund has received research support from ML Bio. The institution of Dr. Wicklund has received research support from Alexion. The institution of Dr. Wicklund has received research support from Acceleron. The institution of Dr. Wicklund has received research support from Edgewise. The institution of Dr. Wicklund has received research support from Fulcrum. The institution of Dr. Wicklund has received research support from Roche-Genentech. The institution of Dr. Wicklund has received research support from Avidity. Dr. Wicklund has received research support from Harmony Bioscience.
Zoe Arvanitakis, MD, MS, FAAN Dr. Arvanitakis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai Inc.. Dr. Arvanitakis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novo Nordisk. Dr. Arvanitakis has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers in Dementia. Dr. Arvanitakis has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for a private legal firm representing a governemental entity. The institution of Dr. Arvanitakis has received research support from National Institutes of Health (NIH). Dr. Arvanitakis has received personal compensation in the range of $500-$4,999 for serving as a Grant reviewer with The National Institutes of Health and California State (California Institute for Regenerative Medicine or CIRM). Dr. Arvanitakis has received personal compensation in the range of $500-$4,999 for serving as a Consultant and Educator with Summus Global, Inc.
S. C. Johnston, MD, PhD, FAAN No disclosure on file
John Hart, MD The institution of Dr. Hart has received research support from Department of Defense.
Hamza I. Maqsood, MD Dr. Qureshi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AstraZeneca.
Elan D. Louis, MD, MS, FAAN Dr. Louis has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wolters Kluwer - Merritt's Textbook of Neurology. Dr. Louis has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Legal Firm. The institution of Dr. Louis has received research support from National Institutes of Health. Dr. Louis has received publishing royalties from a publication relating to health care. Dr. Louis has a non-compensated relationship as a Board of Directors with International Essential Tremor Foundation that is relevant to AAN interests or activities. Dr. Louis has a non-compensated relationship as a Medical Advisory Board with HopeNET that is relevant to AAN interests or activities.
Karl D. Kieburtz, MD Dr. Kieburtz has received personal compensation for serving as an employee of Clintrex Research Corporation. Dr. Kieburtz has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Kieburtz has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. Dr. Kieburtz has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Kieburtz has stock in Clintrex Research Corp. Dr. Kieburtz has stock in Hoover Brown. An immediate family member of Dr. Kieburtz has stock in Hoover Brown. Dr. Kieburtz has stock in Safe Therapeutics. The institution of Dr. Kieburtz has received research support from NIH. The institution of Dr. Kieburtz has received research support from Michae J Fox Foundation.
John C. Morris, MD, FAAN Dr. Morris has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CBR International Advisory Board. Dr. Morris has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cure Alzheimers Fund. Dr. Morris has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for LEADS Steering Commitee. The institution of Dr. Morris has received research support from NIH grants. Dr. Morris has received intellectual property interests from a discovery or technology relating to health care. Dr. Morris has received intellectual property interests from a discovery or technology relating to health care.
Joseph Jankovic, MD, FAAN Dr. Jankovic has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Revance. Dr. Jankovic has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Revance, Allergan. The institution of Dr. Jankovic has received research support from Baylor College of Medicine. Dr. Jankovic has received research support from Abbvie. The institution of Dr. Jankovic has received research support from Abbvie.
Charles H. Adler, MD, PhD, FAAN Dr. Adler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal. Dr. Adler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avion. Dr. Adler has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for CND Life Sci. Dr. Adler has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Jazz. Dr. Adler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Precon. Dr. Adler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurocrine. The institution of Dr. Adler has received research support from NIH. The institution of Dr. Adler has received research support from Michael J. Fox Foundation. The institution of Dr. Adler has received research support from Arizona Biomedical Research Commission. Dr. Adler has received publishing royalties from a publication relating to health care.
Allison Brashear, MD, MBA, FAAN Dr. Brashear has received personal compensation for serving as an employee of McKnight Brain Res Found. Dr. Brashear has received personal compensation for serving as an employee of American Board of Psychiatry and Neurology. Dr. Brashear has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for ABPN. Dr. Brashear has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for McKnight Brain Research Foundation i. Dr. Brashear has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Care Directions- start up . Dr. Brashear has stock in Caredirections . The institution of Dr. Brashear has received research support from NINDS. Dr. Brashear has received publishing royalties from a publication relating to health care. Dr. Brashear has received personal compensation in the range of $500-$4,999 for serving as a Special government employee and study section reviewer with NIH. Dr. Brashear has received personal compensation in the range of $0-$499 for serving as a Adminstrative board -travel reimbursement with AAMC.
Robert D. Brown, Jr., MD, MPH, FAAN Dr. Brown has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Craig H Neilsen Foundation. The institution of Dr. Brown has received research support from National Institutes of Health/NINDS. Dr. Brown has received publishing royalties from a publication relating to health care.
Michel T. Torbey, MD, MPH, FAAN Dr. Torbey has nothing to disclose.
Victor W. Henderson, MD, FAAN Dr. Henderson has stock in Abbott, Amgen, Roche. The institution of Dr. Henderson has received research support from NIH. The institution of Dr. Henderson has received research support from Health IQ. Dr. Henderson has received personal compensation in the range of $500-$4,999 for serving as a External advisory committee member, Alzheimer's Disease Center with University of Kansas. Dr. Henderson has a non-compensated relationship as a adjunct (honorary) professor with Aarhus University that is relevant to AAN interests or activities.
John C. Morgan, MD, PhD Dr. Morgan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amneal. Dr. Morgan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Kyowa Kirin. Dr. Morgan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amneal. Dr. Morgan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Kyowa Kirin. Dr. Morgan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Eisai. Dr. Morgan has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Various Civil Cases. Dr. Morgan has received personal compensation in the range of $5,000-$9,999 for serving as a Rater with Praxis.
Aaron E. Miller, MD, FAAN Dr. Miller has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Accordant Health Services (Caremark). Dr. Miller has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Corevitas (formerly known as Corrona). Dr. Miller has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for MAPI=Pharma. Dr. Miller has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Viatris (Mylan). Dr. Miller has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint Global. Dr. Miller has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gerson Lehrman Group. Dr. Miller has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen Idec. Dr. Miller has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Alexion. Dr. Miller has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amgen (Horizon Therapeutics). Dr. Miller has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Sterne Kessler. Dr. Miller has received publishing royalties from a publication relating to health care.
Joseph I. Sirven, MD, FAAN Dr. Sirven has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Sirven has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurelis. Dr. Sirven has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurona. Dr. Sirven has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. Dr. Sirven has received publishing royalties from a publication relating to health care. Dr. Sirven has received personal compensation in the range of $10,000-$49,999 for serving as a Host/ Co producer with WJCT Public Media. Dr. Sirven has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant with Federal Aviation Administration .
Ettore Beghi, MD, FAAN No disclosure on file
Bruce L. Miller, MD, FAAN Dr. Miller has nothing to disclose.
Virgilio Gerald H. Evidente, MD, FAAN Dr. Evidente has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Revance. Dr. Evidente has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Evidente has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Teva. Dr. Evidente has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Medtronic. Dr. Evidente has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neurocrine. Dr. Evidente has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amneal. Dr. Evidente has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. The institution of Dr. Evidente has received research support from CND. The institution of Dr. Evidente has received research support from Aeon. The institution of Dr. Evidente has received research support from Bukwang Pharmaceuticals. The institution of Dr. Evidente has received research support from Jazz Pharmaceuticals. The institution of Dr. Evidente has received research support from Scion Neurostim. The institution of Dr. Evidente has received research support from Theravance Biopharma. Dr. Evidente has received research support from Cerevance. Dr. Evidente has received research support from Ipsen.
Richard B. Lipton, MD, FAAN Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Allergan/Abbvie. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amgen. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biohaven. Dr. Lipton has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Eli Lilly. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for GlaxoSmithKline. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teva. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vedanta. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Grifols. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Axon. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Satsuma. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cool Tech. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BDSI. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Linpharma. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Axsome. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clexio. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Shiratronics. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan/Abbvie. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Lipton has or had stock in Biohaven.Dr. Lipton has or had stock in Manistee.Dr. Lipton has or had stock in Axon.Dr. Lipton has or had stock in CoolTech. The institution of Dr. Lipton has received research support from Teva. The institution of Dr. Lipton has received research support from Amgen. The institution of Dr. Lipton has received research support from Allergan/Abbvie. The institution of Dr. Lipton has received research support from Gammacore. The institution of Dr. Lipton has received research support from Axsome. The institution of Dr. Lipton has received research support from Charleston Labs. The institution of Dr. Lipton has received research support from Eli Lilly. The institution of Dr. Lipton has received research support from Satsuma. The institution of Dr. Lipton has received research support from NIH . The institution of Dr. Lipton has received research support from Veterans Administration. Dr. Lipton has received publishing royalties from a publication relating to health care.
Ralph L. Sacco, MD, MS, FAHA Dr. Sacco has received personal compensation in the range of $100,000-$499,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Heart Association. The institution of Dr. Sacco has received research support from NIH, NINDS, NCATS, NIMHD. The institution of Dr. Sacco has received research support from FL Department of Health. Dr. Sacco has received research support from University of Washington, Seattle. Dr. Sacco has received publishing royalties from a publication relating to health care.
Bruce A. Cree, MD, PhD, MAS, FAAN The institution of Dr. Cree has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. The institution of Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. The institution of Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. The institution of Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TG Therapeutics. The institution of Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Cree has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neuron23. Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boston Pharma. Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Hexal/Sandoz. Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunic AG. The institution of Dr. Cree has received research support from Genentech. The institution of Dr. Cree has received research support from Kyverna. Dr. Cree has received publishing royalties from a publication relating to health care.
Phillip A. Low, MD, FAAN Dr. Low has nothing to disclose.
Roy L. Freeman, MD Dr. Freeman has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Cutaneous Diagnostic Life Sciences. Dr. Freeman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vertex. Dr. Freeman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Theravance. Dr. Freeman has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Inhibikase. Dr. Freeman has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. The institution of Dr. Freeman has received research support from NIH. The institution of Dr. Freeman has received research support from Theravance. The institution of Dr. Freeman has received research support from Biohaven. The institution of Dr. Freeman has received research support from Lundbeck. Dr. Freeman has received research support from Regeneron.
Stephan A. Mayer, MD Dr. Mayer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ceribell. Dr. Mayer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Phagenesis. Dr. Mayer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ISchemaView. Dr. Mayer has stock in Neuroptics. Dr. Mayer has received publishing royalties from a publication relating to health care.
Hiroshi Mitsumoto, MD, FAAN Dr. Mitsumoto has nothing to disclose.
Christine Klein, MD Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Centogene and Retromer Therapeutics. Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Mov Disord, Ann Neurol, Science Adv. The institution of Dr. Klein has received research support from Centogene. Dr. Klein has received publishing royalties from a publication relating to health care.
Janis M. Miyasaki, MD, MEd, FAAN Dr. Miyasaki has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for 好色先生. Dr. Miyasaki has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Oxford University Press. The institution of Dr. Miyasaki has received research support from PCORI. The institution of Dr. Miyasaki has received research support from Canadian Consortium on Neurodegeneration in Aging. The institution of Dr. Miyasaki has received research support from University Hospital Foundation. The institution of Dr. Miyasaki has received research support from Social Science and Health Research Council. The institution of Dr. Miyasaki has received research support from Parkinson Society Canada. The institution of Dr. Miyasaki has received research support from Parkinson Foundation. The institution of Dr. Miyasaki has received research support from Parkinson Foundation.
Gilles Fenelon, MD, PhD No disclosure on file
Stephen D. Silberstein, MD, FAAN Dr. Silberstein has received publishing royalties from a publication relating to health care.
Anthony E. Lang, MD, FAAN Dr. Lang has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AbbVie, Amylyx, Aprinoia, Biogen, BioAdvance, Biohaven, BioVie, BlueRock, BMS, Denali, Janssen, Lilly, Pharma 2B, Sun Pharma, and UCB. Dr. Lang has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for medicolegal cases related to paraquat. The institution of Dr. Lang has received research support from AbbVie. Dr. Lang has received intellectual property interests from a discovery or technology relating to health care. Dr. Lang has received publishing royalties from a publication relating to health care.
Neeraj Badjatia, MD The institution of Dr. Badjatia has received research support from NIH/DOD.
Wade S. Smith, MD, PhD Dr. Smith has stock in MindRhythm, Inc. The institution of Dr. Smith has received research support from NIH. Dr. Smith has received intellectual property interests from a discovery or technology relating to health care. Dr. Smith has received publishing royalties from a publication relating to health care.
Andrei V. Alexandrov, MD The institution of Dr. Alexandrov has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NovaSignal. Dr. Alexandrov has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NovoNordisc. Dr. Alexandrov has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for AstraZeneca. Dr. Alexandrov has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for American Society of Neuroimaging. Dr. Alexandrov has received publishing royalties from a publication relating to health care.
Benn E. Smith, MD, FAAN Dr. Smith has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Smith has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CSP Behring.
Mark A. Ross, MD, FAAN No disclosure on file
Dean M. Wingerchuk, MD, FAAN Dr. Wingerchuk has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon Therapeutics. Dr. Wingerchuk has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Wingerchuk has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Wingerchuk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Wingerchuk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Meyer Squibb. Dr. Wingerchuk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharma. Dr. Wingerchuk has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AstraZeneca. Dr. Wingerchuk has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Wingerchuk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abcuro. Dr. Wingerchuk has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wolters Kluwers.
Michele Tagliati, MD, FAAN Dr. Tagliati has received publishing royalties from a publication relating to health care.
Lewis B. Morgenstern, MD, FAAN No disclosure on file
Nerissa U. Ko, MD The institution of Dr. Ko has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Route 92, Inc. The institution of Dr. Ko has received research support from American Heart Association. The institution of Dr. Ko has received research support from NIH. The institution of Dr. Ko has received research support from NIH.
Saud Sadiq, BS, FAAN Ms. Brewi has nothing to disclose.
Walter A. Rocca, MD, MPH The institution of Dr. Rocca has received research support from National Institute on Aging - NIH. The institution of Dr. Rocca has received research support from National Heart, Lung, and Blood Institute - NIH.
William W. Campbell, MD, MSHA, FAAN No disclosure on file
Deborah L. Warden, MD No disclosure on file
Richard J. Barohn, MD, FAAN Dr. Barohn has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for NuFactor. The institution of Dr. Barohn has received research support from FDA OPD R01. Dr. Barohn has received intellectual property interests from a discovery or technology relating to health care.
Patricia K. Coyle, MD, FAAN Dr. Coyle has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Accordant. Dr. Coyle has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Coyle has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Sanofi Genzyme. Dr. Coyle has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Coyle has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for GlaxoSmithKline. Dr. Coyle has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Horizon Therapeutics. The institution of Dr. Coyle has received research support from CorEvitas LLC. The institution of Dr. Coyle has received research support from Genentech/Roche. The institution of Dr. Coyle has received research support from NINDS. The institution of Dr. Coyle has received research support from Sanofi Genzyme. The institution of Dr. Coyle has received research support from Cleveland Clinic.
Douglas S. Goodin, MD No disclosure on file
J. E. Ahlskog, MD, PhD Dr. Ahlskog has received publishing royalties from a publication relating to health care.
Julien Bogousslavsky, MD No disclosure on file
Marinos C. Dalakas, MD, FAAN Dr. Dalakas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Grifols, . Dr. Dalakas has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Dysimmune Diseases Foundation. Dr. Dalakas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Octapharma. Dr. Dalakas has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ARGENX. Dr. Dalakas has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. Dr. Dalakas has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Therapeutic Advances in Neurology (TAND). Dr. Dalakas has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Medlink.
Bahram Mokri, MD No disclosure on file
Robert Y. Moore, MD, FAAN No disclosure on file
Jawad F. Kirmani, MD Dr. Kirmani has nothing to disclose.
Merit E. Cudkowicz, MD, MSC, FAAN Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for biogen. Dr. Cudkowicz has received personal compensation in the range of $0-$499 for serving as a Consultant for cytokinetics. Dr. Cudkowicz has received personal compensation in the range of $0-$499 for serving as a Consultant for immunitypharm. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for transposon. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Quralis. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Regeneron. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for vectorY. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for inflectis. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for novartis. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ono. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for otsuka. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for coya. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ac immune. Dr. Cudkowicz has received personal compensation in the range of $0-$499 for serving as a Consultant for pontifax. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Inflectis. Dr. Cudkowicz has received personal compensation in the range of $0-$499 for serving as a Consultant for ab science. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for aclipse. Dr. Cudkowicz has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Locust Walk. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pasithea. Dr. Cudkowicz has received personal compensation in the range of $50,000-$99,999 for serving as an officer or member of the Board of Directors for Praxis Precision Medicine. Dr. Cudkowicz has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Annals of Neurology . The institution of Dr. Cudkowicz has received research support from NINDS. The institution of Dr. Cudkowicz has received research support from ALSFAC. The institution of Dr. Cudkowicz has received research support from UCB ra. The institution of Dr. Cudkowicz has received research support from Biohaven. The institution of Dr. Cudkowicz has received research support from Clene nanomedicine. The institution of Dr. Cudkowicz has received research support from prilenia. The institution of Dr. Cudkowicz has received research support from ALS one. The institution of Dr. Cudkowicz has received research support from Seelos. The institution of Dr. Cudkowicz has received research support from Calico. The institution of Dr. Cudkowicz has received research support from denali. The institution of Dr. Cudkowicz has received research support from ITB. The institution of Dr. Cudkowicz has received research support from PharmAust. The institution of Dr. Cudkowicz has received research support from woolsley. Dr. Cudkowicz has received research support from lilly. The institution of Dr. Cudkowicz has received research support from J& J. Dr. Cudkowicz has received publishing royalties from a publication relating to health care.
Paola Sandroni, MD, PhD, FAAN Dr. Sandroni has nothing to disclose.
Kristine Yaffe, MD Dr. Yaffe has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. Dr. Yaffe has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Quintiles. Dr. Yaffe has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Alector. The institution of Dr. Yaffe has received research support from NIH. The institution of Dr. Yaffe has received research support from DOD. The institution of Dr. Yaffe has received research support from Veterans Affairs.
Jeremy M. Shefner, MD, PhD, FAAN Dr. Shefner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amylyx. Dr. Shefner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Uniqure. Dr. Shefner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clene. Dr. Shefner has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Cytokinetics. Dr. Shefner has received personal compensation in the range of $0-$499 for serving as a Consultant for Mitsubishi Tanabe Pharma America. Dr. Shefner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for annexon. Dr. Shefner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Shefner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Shefner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurosense. Dr. Shefner has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neuvivo. Dr. Shefner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nura BIo. Dr. Shefner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Prilenia. Dr. Shefner has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for swanbio. Dr. Shefner has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for vertex. Dr. Shefner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Shefner has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for UpToDate. The institution of Dr. Shefner has received research support from NIH. The institution of Dr. Shefner has received research support from Mitsubishi Tanabe Pharma America. The institution of Dr. Shefner has received research support from Amylyx. The institution of Dr. Shefner has received research support from BIogen. The institution of Dr. Shefner has received research support from Cytokinetics. The institution of Dr. Shefner has received research support from IONIS. The institution of Dr. Shefner has received research support from Healey Center for ALS. Dr. Shefner has received personal compensation in the range of $500-$4,999 for serving as a grant review chair with DOD- General Dynamics.
Michael S. Okun, MD, FAAN Dr. Okun has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for NIH. Dr. Okun has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Parkinson's Foundation. Dr. Okun has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JAMA Neurology. Dr. Okun has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for NEJM Journal Watch. The institution of Dr. Okun has received research support from NIH. The institution of Dr. Okun has received research support from Parkinson's Foundation. The institution of Dr. Okun has received research support from Tourette Association of America. The institution of Dr. Okun has received research support from Michael J Fox. Dr. Okun has received publishing royalties from a publication relating to health care.
Amit Bar-Or, MD, FRCPC Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche Genentech. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merk/EMD Serono. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for cabaletta. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck/EMD Serono. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi/Genzyme. The institution of Dr. Bar-Or has received research support from Novartis. The institution of Dr. Bar-Or has received research support from Biogen. The institution of Dr. Bar-Or has received research support from Roche/Genentech.
Dennis W. Dickson, MD Dr. Dickson has nothing to disclose.
Karen S. Marder, MD, MPH, FAAN Dr. Marder has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Marder has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Marder has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Parkinson's Foundation . Dr. Marder has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CHDI. Dr. Marder has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PTC therapeutics. Dr. Marder has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer LTD. The institution of Dr. Marder has received research support from Vaccinex. The institution of Dr. Marder has received research support from Genentech. The institution of Dr. Marder has received research support from Triplet Therapeutics. The institution of Dr. Marder has received research support from Prilenia.
Christopher M. Filley, MD, FAAN Dr. Filley has received personal compensation for serving as an employee of University of Colorado Press. Dr. Filley has received personal compensation for serving as an employee of Oxford University Press. Dr. Filley has received personal compensation for serving as an employee of Cambridge University Press . Dr. Filley has received personal compensation for serving as an employee of Elsevier, Inc.. Dr. Filley has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Wheeler Trigg O'Donnell LLP. Dr. Filley has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Evans Case LLP. The institution of Dr. Filley has received research support from Department of Defense. Dr. Filley has received publishing royalties from a publication relating to health care. Dr. Filley has received publishing royalties from a publication relating to health care. Dr. Filley has received publishing royalties from a publication relating to health care. Dr. Filley has received publishing royalties from a publication relating to health care.
Bradley V. Vaughn, MD, FAAN Dr. Vaughn has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Medical 好色先生 Resources. Dr. Vaughn has received publishing royalties from a publication relating to health care. Dr. Vaughn has received publishing royalties from a publication relating to health care. Dr. Vaughn has a non-compensated relationship as a speaker/course director with AAN that is relevant to AAN interests or activities.
Marcelo E. Bigal, MD, PhD No disclosure on file
Catarina Quinzii Hirano, MD No disclosure on file
Omar A. Khan, MD, PhD No disclosure on file
Rahul Rathakrishnan, BM, MRCP No disclosure on file
Catherine Cho, MD Dr. Cho has nothing to disclose.
Vivien H. Lee, MD, FAAN Dr. Lee has nothing to disclose.
Muhammad Qureshi, MD No disclosure on file
Soham Sheth, MD Dr. Sheth has nothing to disclose.
Robert Goodman No disclosure on file
Mamatha Pasnoor, MD, FAAN Dr. Pasnoor has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Argenx BVBA. Dr. Pasnoor has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen Pharmaceutical. Dr. Pasnoor has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovant. Dr. Pasnoor has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Pasnoor has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Annexon. Dr. Pasnoor has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Grifols. Dr. Pasnoor has received personal compensation in the range of $500-$4,999 for serving as a Consultant for amgen.
Marc Gotkine, MD No disclosure on file
Tsutomu Nakada, MD, PhD No disclosure on file
Marwan N. Sabbagh, MD, FAAN Dr. Sabbagh has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eisai. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genetech=Roche. Dr. Sabbagh has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novo Nordisk. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lilly. Dr. Sabbagh has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Synaptogenix. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Signant Health. Dr. Sabbagh has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Anavex. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cognito Therapeutics. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GSK. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Sabbagh has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for CervoMed. Dr. Sabbagh has stock in Neurotau. Dr. Sabbagh has stock in Seq Biomarque. Dr. Sabbagh has stock in uMethod Health. Dr. Sabbagh has stock in Athira. Dr. Sabbagh has stock in Lighthouse Pharmaceuticals. Dr. Sabbagh has stock in Alzheon. The institution of Dr. Sabbagh has received research support from NIH. The institution of Dr. Sabbagh has received research support from ADDF.
Christine Lebrun Frenay, MD, FAAN Dr. Lebrun Frenay has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Revue Neurologique. The institution of Dr. Lebrun Frenay has received research support from FRANCE SEP.
Marc Debouverie, MD Dr. Debouverie has nothing to disclose.
Pierre Clavelou, MD, PhD Dr. Clavelou has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Clavelou has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Clavelou has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck.
No disclosure on file
Gilles Defer, MD Dr. Defer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Defer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen . Dr. Defer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis . Dr. Defer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche.
Veronique Bourg No disclosure on file
Mary Ganguli, MD, MPH No disclosure on file
Hiroko H. Dodge, PhD No disclosure on file
Jose A. Suros, MD No disclosure on file
Susanne Muehlschlegel, MD, MPH, FAAN Dr. Muehlschlegel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Grace Pharmaceuticals Inc.. Dr. Muehlschlegel has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Grace Pharmaceuticals Inc.. The institution of Dr. Muehlschlegel has received research support from NIH. The institution of Dr. Muehlschlegel has received research support from NIH. The institution of an immediate family member of Dr. Muehlschlegel has received research support from NIH. The institution of Dr. Muehlschlegel has received research support from Johns Hopkins Stimulating and Advancing Anesthesiology & Critical Care Medicine Research (StAAR) Award. The institution of Dr. Muehlschlegel has received research support from Trustees of The Patrick and Catherine Weldon Donaghue Medical Research Foundation. The institution of Dr. Muehlschlegel has received research support from Harkin Family Fund (Johns Hopkins Dept. of Neurology). Dr. Muehlschlegel has received personal compensation in the range of $500-$4,999 for serving as a Speaker and Author with 好色先生. Dr. Muehlschlegel has a non-compensated relationship as a Member of Board of Directors with Neurocritical Care Society that is relevant to AAN interests or activities. Dr. Muehlschlegel has a non-compensated relationship as a Officer of the Board of Directors with Neurocritical Care Society that is relevant to AAN interests or activities.
Pierre Krystkowiak, MD, PhD No disclosure on file
Luc Defebvre No disclosure on file
Alain Destee, MD, PhD No disclosure on file
Ely S. Simon, MD No disclosure on file
Glen M. Doniger, PhD No disclosure on file
Gregory Christoforidis No disclosure on file
Oded Abramsky, MD, PhD, FAAN No disclosure on file
Adriano Chio, MD, FAAN Dr. Chio has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cytokinetics. Dr. Chio has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi. Dr. Chio has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Chio has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Corcept.
Augusto Gauthier, PsyD No disclosure on file
Alessandro Vignola, PsyD No disclosure on file
Andrea Calvo, MD, PhD, FAAN Dr. Calvo has nothing to disclose.
Paolo Ghiglione, MD No disclosure on file
Midori A. Yenari, MD, FAAN No disclosure on file
Xiannan Tang, MD, PhD No disclosure on file
Andrew McKeon, MD The institution of Dr. McKeon has received research support from National Institutes of Health. Dr. McKeon has received intellectual property interests from a discovery or technology relating to health care. Dr. McKeon has received intellectual property interests from a discovery or technology relating to health care. Dr. McKeon has received publishing royalties from a publication relating to health care.
Orla Hardiman, MD, DSc, FRCPI, MRIA, FAAN Dr. Hardiman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Wave Pharmaceuticals. Dr. Hardiman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cytokinetics . Dr. Hardiman has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Hardiman has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Taylor and Francis. The institution of Dr. Hardiman has received research support from Science Foundation Ireland. The institution of Dr. Hardiman has received research support from HRB.
Nereo Bresolin, DR No disclosure on file
James M. Gee No disclosure on file
Shweta Antani No disclosure on file
Gwyneth M. McCawley, MD No disclosure on file
Peachie N. Moore, BA No disclosure on file
Murray Grossman, MD, FAAN Dr. Grossman has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology. The institution of Dr. Grossman has received research support from NIH.
Spyridon Papapetropoulos, MD, PhD Dr. Papapetropoulos has received personal compensation for serving as an employee of Vigil Neuroscience . Dr. Papapetropoulos has received personal compensation for serving as an employee of Bionomics Ltd. Dr. Papapetropoulos has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Lipocine Inc. Dr. Papapetropoulos has stock in Vigil Neuroscience. Dr. Papapetropoulos has stock in Lipocine. Dr. Papapetropoulos has stock in Bionomics Ltd.
Deborah C. Mash, PhD No disclosure on file
David Devos The institution of Mr. Devos has received research support from Alterity.
Katy Dujardin No disclosure on file
Timothy L. Vollmer, MD, FAAN The institution of Dr. Vollmer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen IDEC. The institution of Dr. Vollmer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech/Roche. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Siranax. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Celgene. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Meyers Squib. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Viela Bios. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. The institution of Dr. Vollmer has received research support from Rocky Mountain MS Center. The institution of Dr. Vollmer has received research support from Biogen. The institution of Dr. Vollmer has received research support from Actelion. The institution of Dr. Vollmer has received research support from Genentech/Roche. The institution of Dr. Vollmer has received research support from Anokion. The institution of Dr. Vollmer has received research support from TG Therapeutics.
Fu-Dong Shi, MD, PhD No disclosure on file
Marie-Laure Welter No disclosure on file
Denise I. Campagnolo, MD, MS Dr. Campagnolo has received personal compensation for serving as an employee of Biogen. Dr. Campagnolo has received stock or an ownership interest from Biogen.
Kevin R. Scott, MD, FAAN No disclosure on file
Zachary Simmons, MD, FAAN Dr. Simmons has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amylyx. Dr. Simmons has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clene. Dr. Simmons has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Insmed. Dr. Simmons has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Simmons has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Corcept. The institution of Dr. Simmons has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wiley. The institution of Dr. Simmons has received research support from MGH. The institution of Dr. Simmons has received research support from Clene. The institution of Dr. Simmons has received research support from NIH via MGH. The institution of Dr. Simmons has received research support from Aburo. The institution of Dr. Simmons has received research support from NIH subaward via Univ of Pennsylvania.
Helen E. Stephens No disclosure on file
Qing Yang, PhD No disclosure on file
Anat Achiron, MD, PhD, FAAN Dr. Achiron has nothing to disclose.
Leiming Zhang, PhD No disclosure on file
Julian Benito-Leon No disclosure on file
Mark S. LeDoux, MD, PhD No disclosure on file
Daniel L. Menkes, MD, FAAN An immediate family member of Dr. Menkes has received personal compensation for serving as an employee of NIH. An immediate family member of Dr. Menkes has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for CMTE. An immediate family member of Dr. Menkes has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NIH. Dr. Menkes has received personal compensation in the range of $100,000-$499,999 for serving as an Expert Witness for Self Employed. An immediate family member of Dr. Menkes has received research support from Helmsley Foundation . An immediate family member of Dr. Menkes has received intellectual property interests from a discovery or technology relating to health care.
Jianfeng Xiao No disclosure on file
Felix Bermejo-Pareja, MD No disclosure on file
Douglas L. Arnold, MD, FAAN Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BMS. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Frequency Therapeutics. Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck. Dr. Arnold has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Arnold has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Shionogi. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Xfacto communications. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Find therapeutics. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GSK. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Idorsia. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kiniksa. Dr. Arnold has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Clario.
Georgios M. Hadjigeorgiou, MD No disclosure on file
Sridar Narayanan Sridar Narayanan has received personal compensation for serving as an employee of NeuroRx Research. Sridar Narayanan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech Inc.. The institution of Sridar Narayanan has received research support from Immunotec Inc.
Yves L. Lapierre, MD No disclosure on file
Andrea Bernasconi, MD No disclosure on file
Daria A. Trojan, MD No disclosure on file
Amy Wong No disclosure on file
Zografos Caramanos No disclosure on file
Alberto Ascherio, MD, PhD Dr. Ascherio has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Pfizer. Dr. Ascherio has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Dr. Ascherio has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. The institution of Dr. Ascherio has received research support from NIH and US Department of Defense .
Kassandra L. Munger Ms. Munger has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. The institution of Ms. Munger has received research support from Department of Defense.
Demetrius M. Maraganore, MD, FAAN Dr. Maraganore has nothing to disclose.
Norman Putzki, MD No disclosure on file
Volker Limmroth, MD, PhD No disclosure on file
Helene Zephir Helene Zephir has received personal compensation in the range of $0-$499 for serving as a Consultant for BIogen Idec. Helene Zephir has received personal compensation in the range of $0-$499 for serving as a Consultant for novartis. Helene Zephir has received personal compensation in the range of $0-$499 for serving as a Consultant for BMS. Helene Zephir has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion.
Patrick Vermersch Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AB Science. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Imcyse. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS-Celgene. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ad Scientiam. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for La revue des microbiotes. The institution of Patrick Vermersch has received research support from Roche. The institution of Patrick Vermersch has received research support from Sanofi.
Julie A. Fields, BA No disclosure on file
Alexander I. Troster, PhD Dr. Troster has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic. Dr. Troster has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Dr. Troster has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sage Therapeutics. Dr. Troster has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Cambridge University Press/International Neuropsychological Society. The institution of Dr. Troster has received research support from Barrow Neurological Foundation. Dr. Troster has received publishing royalties from a publication relating to health care.
Robert D. Fealey, MD No disclosure on file
Catherine M. Roe, PhD No disclosure on file
Chengjie Xiong, PhD Chengjie Xiong has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for DIADEM.
Takayoshi Shimohata, MD, FAAN Dr. Shimohata has nothing to disclose.
Heng Zhao, PhD No disclosure on file
Gary Steinberg, MD, PhD Dr. Steinberg has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for SanBio. Dr. Steinberg has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Zeiss. Dr. Steinberg has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Surgical Theater. Dr. Steinberg has received research support from National Institutes of Health. Dr. Steinberg has received research support from California Institute of Regenerative Medicine. Dr. Steinberg has received intellectual property interests from a discovery or technology relating to health care.
Rosana H. Scola, MD Dr. Scola has nothing to disclose.
Lineu C. Werneck, MD No disclosure on file
John H. Wokke, MD, PhD No disclosure on file
Tariq Alafifi, MD No disclosure on file
Ralph Z. Kern, MD Dr. Kern has received personal compensation for serving as an employee of Cognito Therapeutics. Dr. Kern has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharmatrophix. Dr. Kern has or had stock in Cognito Therapeutics.
Anita L. Belman, MD, FAAN No disclosure on file
Christopher Christodoulou, PhD No disclosure on file
Lauren B. Krupp, MD, FAAN Dr. krupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb. Dr. krupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Celgene. Dr. krupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medscape. Dr. krupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EBIX. Dr. krupp has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. krupp has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hoffman LaRoche. Dr. krupp has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for MMMK. Dr. krupp has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Patrick, Dolan, and Kaufman. Dr. krupp has received intellectual property interests from a discovery or technology relating to health care.
Brandon R. Grossardt, MS No disclosure on file
James H. Bower, MD, MSc, FAAN The institution of Dr. Bower has received research support from Abbvie.
Roberta Frigerio, MD Dr. Frigerio has nothing to disclose.
Javier Olazaran, MD No disclosure on file
Wengui Yu, MD, PhD Dr. Yu has nothing to disclose.
Maria Luisa Gorno Tempini, MD, PhD The institution of Dr. Gorno Tempini has received research support from the NIH.
Jesus Rivera Navarro No disclosure on file
Peter A. Calabresi, MD, FAAN Dr. Calabresi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Calabresi has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Idorsia. An immediate family member of Dr. Calabresi has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MyMD. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Myelin Repair Foundation. The institution of Dr. Calabresi has received research support from Genentech. Dr. Calabresi has received publishing royalties from a publication relating to health care. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving as a Study Section Member with NIH. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving as a Grant reveiwer with Myelin Repair Foundation. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving as a Speaker for CME with NYAS. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Academic CME.
Andrew D. Goodman, MD, FAAN Dr. Goodman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Swan Bio. Dr. Goodman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Goodman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Goodman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lilly. Dr. Goodman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Goodman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Goodman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for IMCYSE. Dr. Goodman has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Pfizer. The institution of Dr. Goodman has received research support from Atara. The institution of Dr. Goodman has received research support from Genzyme. The institution of Dr. Goodman has received research support from EMD-Serono.
Ellen Schoenberger, RPh No disclosure on file
Charlene R. Hoffman-Snyder, DNP No disclosure on file
E P. Bosch, MD, FAAN No disclosure on file
Maurice Giroud No disclosure on file
Isabelle Benatru, MD No disclosure on file
Olivier Rouaud, MD Dr. Rouaud has nothing to disclose.
Fabienne Contegal No disclosure on file
Guy Victor Osseby, MD No disclosure on file
Alexandre Kreisler No disclosure on file
Jean Pouget, MD, PhD No disclosure on file
Ruggero Capra, MD Dr. Capra has nothing to disclose.
Cinzia Cordioli, MD Dr. Cordioli has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Almirall. Dr. Cordioli has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Cordioli has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis.
Roberto Bergamaschi Roberto Bergamaschi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Roberto Bergamaschi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Roberto Bergamaschi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Roberto Bergamaschi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Roberto Bergamaschi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Roberto Bergamaschi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Roberto Bergamaschi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi.
Luisa Imberti No disclosure on file
Byung-Chul Lee, MD, PhD No disclosure on file
Simona M. Brambati, MD No disclosure on file
Robert P. Lisak, MD, FAAN Dr. Lisak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argnex. Dr. Lisak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GLG Consulting. Dr. Lisak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Third Bridge Consulting. Dr. Lisak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clearview Consulting. Dr. Lisak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Dr. Lisak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alivar Therapeutics. Dr. Lisak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ANI Pharmaceuticals. Dr. Lisak has received personal compensation in the range of $0-$499 for serving as a Consultant for Coleman Research. Dr. Lisak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon. Dr. Lisak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunic. Dr. Lisak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint Consulting. Dr. Lisak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Tedus Consulting. Dr. Lisak has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for COUR Pharma. The institution of Dr. Lisak has received research support from NINDS. The institution of Dr. Lisak has received research support from Argenx. The institution of Dr. Lisak has received research support from Ra Pharmaceuticals. Dr. Lisak has received publishing royalties from a publication relating to health care. Dr. Lisak has received publishing royalties from a publication relating to health care.
Nadine Fisher No disclosure on file
Paul Zak No disclosure on file
Lori D. Uber-Zak, DO No disclosure on file
Jean P. Azulay, MD Dr. Azulay has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for abbvie. Dr. Azulay has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier.
Giancarlo Logroscino, MD, PhD, FAAN Dr. Logroscino has nothing to disclose.
Paolo Lamberti No disclosure on file
Isabella L. Simone No disclosure on file
Luigi M. Serlenga No disclosure on file
Hubert H. Fernandez, MD, FAAN Dr. Fernandez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Fernandez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal. Dr. Fernandez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Intrance. Dr. Fernandez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Fernandez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Fernandez has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Fernandez has received publishing royalties from a publication relating to health care. Dr. Fernandez has received personal compensation in the range of $10,000-$49,999 for serving as a Steering Committee/Advisory Committee Member with Parkinson Study Group.
Lindsy N. Williams, MD No disclosure on file
Gregory Crucian No disclosure on file
Dawn Bowers, PhD No disclosure on file
Joe Verghese, MD, FAAN Dr. Verghese has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MedRhythms Inc. The institution of Dr. Verghese has received research support from National Institutes of Health.
Bruno Dubois, MD No disclosure on file
Jaime Kulisevsky, MD, PhD Dr. Kulisevsky has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Esteve. Dr. Kulisevsky has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Britannia. Dr. Kulisevsky has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AC Immune. Dr. Kulisevsky has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bial. Dr. Kulisevsky has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Zambon. Dr. Kulisevsky has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Britannia.
Javier Pagonabarraga Javier Pagonabarraga has nothing to disclose.
Berta Maria Pascual Sedano No disclosure on file
Philippe P. Derost No disclosure on file
Franck Durif, MD, PhD No disclosure on file
Elcio J. Piovesan, MD Dr. Piovesan has nothing to disclose.
Giovanni Savettieri, MD No disclosure on file
Gabriele Mora, MD Dr. Mora has nothing to disclose.
Roberto D'Alessandro, MD No disclosure on file
Fabrizio Salvi, MD No disclosure on file
Rudolf Schoenhuber, MD, MBA No disclosure on file
Graziella Filippini, MD No disclosure on file
Vincenzo Silani, MD, FAAN Dr. Silani has nothing to disclose.
Guido Cavalletti, MD No disclosure on file
Pierangelo Barbero, MD No disclosure on file
Bruno Ferrero No disclosure on file
Luca Durelli, MD No disclosure on file
Alessandra Ricci No disclosure on file
Marinella Clerico, MD Dr. Clerico has nothing to disclose.
OPTIMS Study Group No disclosure on file
Andrea Sovera Andrea Rovera has received personal compensation for serving as an employee of Philips.
Rui Pedrosa, MD No disclosure on file
Armando Sena, MD, PhD No disclosure on file
Maria Morais No disclosure on file
Anna Terreni No disclosure on file
Gerald Devuyst, MD No disclosure on file
Cornelis J. Stam, MD, PhD No disclosure on file
Arjen J. Slooter, MD No disclosure on file
Elisabeth Vriens No disclosure on file
Zhen Hong, MD No disclosure on file
Ding Ding, MD, MPH No disclosure on file
Amy R. Borenstein, PhD, FAAN No disclosure on file
Robert Zivadinov, MD, PhD, FAAN The institution of Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. The institution of Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Omnicuris. The institution of Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Myrobalan. Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Zivadinov has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono. Dr. Zivadinov has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Bristol Myers Squibb. The institution of Dr. Zivadinov has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen.
Gary Hunter, MD No disclosure on file
Jan Claassen, MD, PhD Dr. Claassen has stock in iCE Neurosystems. The institution of Dr. Claassen has received research support from NINDS. The institution of Dr. Claassen has received research support from McDonnel Foundation. Dr. Claassen has received publishing royalties from a publication relating to health care. Dr. Claassen has received publishing royalties from a publication relating to health care.
Fred Rincon, MD Dr. Rincon has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for NeuroCrit, LLC. Dr. Rincon has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for NeuroCrit LLC.
Israel Steiner, MD No disclosure on file
Steven R. Schwid, MD, FAAN No disclosure on file
Iftah Biran, MD No disclosure on file
Marie Sarazin No disclosure on file
Augusto Parra, MD, MPH Dr. Parra has nothing to disclose.
Pushpa Narayanaswami, MD, MBBS, FAAN Dr. Narayanaswami has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for UCB. Dr. Narayanaswami has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CVS. Dr. Narayanaswami has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Narayanaswami has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Narayanaswami has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx USA. Dr. Narayanaswami has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Narayanaswami has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Narayanaswami has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for NMD pharma. Dr. Narayanaswami has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD-Serono (Merck usa). Dr. Narayanaswami has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Immuneabs. Dr. Narayanaswami has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Viridian. Dr. Narayanaswami has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cabaletta-Bio. Dr. Narayanaswami has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunovant. Dr. Narayanaswami has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Narayanaswami has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Dianthus. Dr. Narayanaswami has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cartesian. Dr. Narayanaswami has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Vor Bio. Dr. Narayanaswami has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Muscle and Nerve, Wiley. Dr. Narayanaswami has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology. Dr. Narayanaswami has or had stock in Dr. Reddys laboratories.Dr. Narayanaswami has or had stock in Doximity. The institution of Dr. Narayanaswami has received research support from Alexion. The institution of Dr. Narayanaswami has received research support from NIH. The institution of Dr. Narayanaswami has received research support from Argenx. The institution of Dr. Narayanaswami has received research support from Cabaletta Bio. Dr. Narayanaswami has received publishing royalties from a publication relating to health care. Dr. Narayanaswami has a non-compensated relationship as a Member, Finance Committee with AANEM that is relevant to AAN interests or activities.
Shigeki Tamura No disclosure on file
Shizuo Nakamura, PhD No disclosure on file
Michael Schwarzschild, MD, PhD The institution of Dr. Schwarzschild has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bial Biotech (indirectly, as a service of the Parkinson Study Group service). The institution of Dr. Schwarzschild has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen (indirectly, as a service of the Parkinson Study Group service). The institution of Dr. Schwarzschild has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB (indirectly, as a service of the Parkinson Study Group service). Dr. Schwarzschild has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. The institution of Dr. Schwarzschild has received research support from NIH. The institution of Dr. Schwarzschild has received research support from Parkinson's Foundation. The institution of Dr. Schwarzschild has received research support from Michael J Fox Foundation. The institution of Dr. Schwarzschild has received research support from Farmer Family Foundation. Dr. Schwarzschild has a non-compensated relationship as a Chair, Executive Committee with the Parkinson Study Group that is relevant to AAN interests or activities.
Marc Weisskopf, PhD Prof. Weisskopf has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kaiser Permanente Research Biobank. The institution of Prof. Weisskopf has received research support from ALS Network. The institution of Prof. Weisskopf has received research support from NIH. The institution of Prof. Weisskopf has received research support from Paralyzed Veterans of America. The institution of Prof. Weisskopf has received research support from CDC/ATSDR. The institution of Prof. Weisskopf has received research support from JPB Foundation.
Honglei Chen, MD, PhD No disclosure on file
Karen M. Thomas, DO No disclosure on file
Sandra K. Kostyk, MD, PhD Dr. Kostyk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for WaveLifeScience. Dr. Kostyk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Kostyk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Kostyk has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Prilenia Therapeutics. The institution of Dr. Kostyk has received research support from Michael J Fox Foundation. The institution of Dr. Kostyk has received research support from Craig Nielsen Foundation. The institution of Dr. Kostyk has received research support from CHDI Foundaton. The institution of Dr. Kostyk has received research support from UniQure. The institution of Dr. Kostyk has received research support from Voyager Therapeutics. The institution of Dr. Kostyk has received research support from WaveLife Sciences. The institution of Dr. Kostyk has received research support from Vaccinex . The institution of Dr. Kostyk has received research support from Neurocrine Biosciences. The institution of Dr. Kostyk has received research support from Prilenia.
David Q. Beversdorf, MD, FAAN Dr. Beversdorf has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Yamo pharmaceuticals. Dr. Beversdorf has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Autism Research Institute. Dr. Beversdorf has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier (Research in Autism Spectrum Disorders). The institution of Dr. Beversdorf has received research support from Autism Research Institute. Dr. Beversdorf has received personal compensation in the range of $5,000-$9,999 for serving as a Case Consultant with Best Doctors.
Douglas A. Kerr, MD, PhD Dr. Kerr has received personal compensation for serving as an employee of Dyne Therapeutics. Dr. Kerr has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for BlueRock Therapeutics. Dr. Kerr has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Trace Neuroscience. Dr. Kerr has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Spolia Therapeutics. Dr. Kerr has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for BlueRock Therapeutics. Dr. Kerr has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for AAVantgarde Therrapeutics. Dr. Kerr has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Trace Neuroscience. Dr. Kerr has or had stock in Dyne Therapeutics.
Francine Grodstein No disclosure on file
Mohamad Koubeissi, MD, FAAN Dr. Koubeissi has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for SK Life Sciences.
Nathan E. Crone, MD No disclosure on file
Alon Sinai, PhD No disclosure on file
Lawrence S. Honig, MD, PhD, FAAN Dr. Honig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Honig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Honig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medscape. Dr. Honig has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Prevail. Dr. Honig has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cortexyme. Dr. Honig has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Legal Firms . The institution of Dr. Honig has received research support from Roche. The institution of Dr. Honig has received research support from Eisau. Dr. Honig has received research support from Alector. The institution of Dr. Honig has received research support from Transposon.
Emmanuelle Le Page Emmanuelle Le Page has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for MERCK. Emmanuelle Le Page has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis.
Philippe Cabre, MD No disclosure on file
Sandrine Wiertlewski No disclosure on file
David Laplaud No disclosure on file
Jean Pelletier, MD, PhD Dr. Pelletier has nothing to disclose.
Irina Malikova No disclosure on file
Olivier F. Gout, MD Dr. Gout has nothing to disclose.
Clotilde Boulay No disclosure on file
Gilles Edan, MD No disclosure on file
Gregory Couvreur No disclosure on file
Marco Salvetti, MD Dr. Salvetti has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for sanofi. Dr. Salvetti has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for biogen. The institution of Dr. Salvetti has received research support from bms.
Nicolas Schmidt No disclosure on file
Olivier Joyeux, MD No disclosure on file
Veronique Souvignet No disclosure on file
Hans-Peter Hartung, MD, FAAN Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS Celgene. Dr. Hartung has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Geneuro. Dr. Hartung has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Hartung has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bayer. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers Neurology.
Ludwig Kappos, MD, FAAN Dr. Kappos has nothing to disclose.
Masatoyo Nishizawa, MD No disclosure on file
Stefania Corti, MD, PhD Dr. Corti has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Corti has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Corti has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta.
John M. Ravits, MD, FAAN Dr. Ravits has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Iris, Inc. Dr. Ravits has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Maze, Inc. Dr. Ravits has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Transposon, Inc. Dr. Ravits has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Libra, Inc. The institution of Dr. Ravits has received research support from NIH R21 Research Grant. The institution of Dr. Ravits has received research support from NIH R01 Research Grant. The institution of Dr. Ravits has received research support from FightMND Foundation Research Grant. The institution of Dr. Ravits has received research support from DOD Research Grant. Dr. Ravits has received personal compensation in the range of $0-$499 for serving as a Reviewer with NIH Office of Scientific Review.
Kun Qu No disclosure on file
Charles Bernick, MD Dr. Bernick has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. Dr. Bernick has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Optina. Dr. Bernick has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai. Dr. Bernick has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Corium. Dr. Bernick has stock in Aurora. The institution of Dr. Bernick has received research support from UFC. The institution of Dr. Bernick has received research support from Top Rank Promotions. The institution of Dr. Bernick has received research support from Haymon Boxing.
Kate Young No disclosure on file
Muhammad F. Suri, MD Dr. Suri has nothing to disclose.
Mustapha A. Ezzeddine, MD, FAAN The institution of Dr. Ezzeddine has received research support from NIH.
Abu Nasar No disclosure on file
Barry S. Oken, MD, PhD, FAAN Dr. Oken has nothing to disclose.
Jeffrey A. Kaye, MD, FAAN Dr. Kaye has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Kaye has stock in Life Analytics. The institution of Dr. Kaye has received research support from NIH. The institution of Dr. Kaye has received research support from NSF. The institution of Dr. Kaye has received research support from AbbVie. Dr. Kaye has received intellectual property interests from a discovery or technology relating to health care.
Diane Howieson, PhD No disclosure on file
Abraham A. Ashkenazi, MD No disclosure on file
Devin L. Brown, MD, FAAN The institution of Dr. Brown has received research support from NIH.
Kirsten L. Gruis, MD No disclosure on file
Christina Caon, RN, BS Ms. Caon has received personal compensation for serving as an employee of EMD Serono.
Fen Bao Fen Bao has nothing to disclose.
Nancy K. Hills, PhD No disclosure on file
Gareth J. Parry, MD Dr. Parry has nothing to disclose.
Sonia Ancoli-Israel, PhD No disclosure on file
Deborah E. Barnes, PhD, MPH The institution of Dr. Barnes has received research support from the National Institutes of Health, Department of Veterans Affairs, Department of Defense, Alzheimer's Association, and the California Department of Public Health.
Olivier Outteryck Olivier Outteryck has nothing to disclose.
Gary R. Cutter, PhD Dr. Cutter has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for onsulting or Advisory Boards: Alexion, Antisense Therapeutics/Percheron, Avotres, Biogen, Clene Nanomedicine, Clinical Trial Solutions LLC, Endra Life Sciences, Cognito Therapeutics, Genzyme, Genentech, Immunic, Klein-Buendel Incorporated, Kyverna Therapeutics, Inc. , Linical, Merck/Serono, Noema, Neurogenesis, Perception Neurosciences, Protalix Biotherapeutics, Regeneron, Revelstone Consulting, Roche, SAB Biotherapeutics, Sapience Therapeutics, Scott&Scott LLP, Tenmile.. Dr. Cutter has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Data and Safety Monitoring Boards: Applied Therapeutics, AI therapeutics, AMO Pharma, Argenx, Astra-Zeneca, Avexis Pharmaceuticals, Bristol Meyers Squibb, CSL Behring, Cynata Therapeutics, DiamedicaTherapeutics, Horizon Pharmaceuticals, Immunic, Inhibrix, Karuna Therapeutics, Kezar Life Sciences, Medtronic, Merck, Meiji Seika Pharma, Mitsubishi Tanabe Pharma Holdings, Prothena Biosciences, Novartis, Pipeline Therapeutics (Contineum), Regeneron, Sanofi-Aventis, Teva Pharmaceuticals, United BioSource LLC, University of Texas Southwestern.. Dr. Cutter has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JASN.
Ruth-Ann Marrie, MD, PhD The institution of Dr. Marrie has received research support from CIHR. The institution of Dr. Marrie has received research support from MS Canada. The institution of Dr. Marrie has received research support from National MS Society. The institution of Dr. Marrie has received research support from Crohn's and Colitis Canada. The institution of Dr. Marrie has received research support from US Department of Defense. The institution of Dr. Marrie has received research support from The Arthritis Society. The institution of Dr. Marrie has received research support from CMSC.
Noah Rosen, MD, FAAN Dr. Rosen has received personal compensation for serving as an employee of Northwell Health. An immediate family member of Dr. Rosen has received personal compensation for serving as an employee of New York University. Dr. Rosen has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Allergan/ Abbvie. Dr. Rosen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Rosen has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer . Dr. Rosen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal. Dr. Rosen has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Allergan/ Abbvie. Dr. Rosen has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Pfizer. Dr. Rosen has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer.
Tanya Stojkovic Tanya Stojkovic has nothing to disclose.
Yves Agid, MD, PhD No disclosure on file
Michael Schupbach, MD No disclosure on file
Andrew D. Siderowf, MD Dr. Siderowf has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Siderowf has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi. Dr. Siderowf has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boehringer-Ingelheim. Dr. Siderowf has received personal compensation in the range of $500-$4,999 for serving as a Consultant for askbio. Dr. Siderowf has received personal compensation in the range of $500-$4,999 for serving as a Consultant for capsida. Dr. Siderowf has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Parkinson Study Group. Dr. Siderowf has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Theravance. Dr. Siderowf has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurocrine. Dr. Siderowf has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Prilenia. Dr. Siderowf has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Wave. Dr. Siderowf has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurogastrix. Dr. Siderowf has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Prevail. Dr. Siderowf has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alerity. Dr. Siderowf has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Clintrex. Dr. Siderowf has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Inhibikase. Dr. Siderowf has a non-compensated relationship as a Scientific Advisory Board with NeuroPacs that is relevant to AAN interests or activities.
Matthew B. Stern, MD Dr. Stern has received personal compensation for serving as an employee of Mediflix, Inc. Dr. Stern has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for biogen. Dr. Stern has received personal compensation in the range of $100,000-$499,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neuroderm.
B J. Connolly No disclosure on file
Eduardo E. Benarroch, MD, FAAN Dr. Benarroch has nothing to disclose.
Anna Ferrier, MD No disclosure on file
Rana K. Zabad, MD, FAAN Dr. Zabad has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer. Dr. Zabad has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Zabad has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Zabad has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Celgene/BMS. Dr. Zabad has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genzyme. Dr. Zabad has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck Serono. Dr. Zabad has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva Neurosciences. Dr. Zabad has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Zabad has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva. Dr. Zabad has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Zabad has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Genentech. Dr. Zabad has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for BMS. The institution of Dr. Zabad has received research support from Adamas. The institution of Dr. Zabad has received research support from Biogen. The institution of Dr. Zabad has received research support from Novartis. The institution of Dr. Zabad has received research support from Sun Pharma. The institution of Dr. Zabad has received research support from Parexel & MedDay Pharmaceuticals.
Alexandros C. Tselis, MD, PhD No disclosure on file
Megan L. Mackenzie, DO No disclosure on file
Gary Swan No disclosure on file
Dorit Carmelli, PhD No disclosure on file
Christina Lessov-Schlaggar, PhD No disclosure on file
Deena Lisak, RN, MSCN, MA No disclosure on file
Burk Jubelt, MD No disclosure on file
Carol Moore No disclosure on file
Ramon R. Diaz-Arrastia, MD, PhD, FAAN Dr. Diaz-Arrastia has stock in BrainBox, LLC. Dr. Diaz-Arrastia has stock in Nia Therpeutics. The institution of Dr. Diaz-Arrastia has received research support from National Institutes of Health. The institution of Dr. Diaz-Arrastia has received research support from Department of Defense.
Caryn Harper No disclosure on file
Vanessa Troiani No disclosure on file
Kelly Claire Simon, ScD No disclosure on file
Paul A. Lapchak, PhD, FAHA No disclosure on file
Frederick G. Freitag, DO No disclosure on file
Michael L. Reed, PhD The institution of Dr. Reed has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eli Lilly. The institution of Dr. Reed has received research support from Allergan. The institution of Dr. Reed has received research support from Dr Reddy's Labs/Promius. The institution of Dr. Reed has received research support from Allay Lamp. Dr. Reed has a non-compensated relationship as a Research Analyst with National Headache Foundation that is relevant to AAN interests or activities.
Walter Stewart, MD No disclosure on file
Valerie Voon, MD FRCPC No disclosure on file
Kamaldeen R. Saldin, MD No disclosure on file
Melissa Tir No disclosure on file
Clemence Simonin, MD No disclosure on file
Theresa A. Zesiewicz, MD Dr. Zesiewicz has received personal compensation for serving as an employee of Medscape. Dr. Zesiewicz has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lexeo. Dr. Zesiewicz has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Steminent. Dr. Zesiewicz has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Larimar. Dr. Zesiewicz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven. Dr. Zesiewicz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Zesiewicz has received intellectual property interests from a discovery or technology relating to health care. Dr. Zesiewicz has received intellectual property interests from a discovery or technology relating to health care. Dr. Zesiewicz has received intellectual property interests from a discovery or technology relating to health care.
Peter B. Dunne, MD, FAAN No disclosure on file
Kelly Sullivan, PhD Dr. Sullivan has received intellectual property interests from a discovery or technology relating to health care.
Christopher Ward, MD No disclosure on file
Joseph Staffetti, MD Joseph Staffetti has nothing to disclose.
Margy E. McCullough-Hicks, MD Dr. McCullough-Hicks has received research support from 好色先生 (Lawrence M. Brass Stroke Research Award).
Holly A. Shill, MD, FAAN Dr. Shill has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sage Biogen. Dr. Shill has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Shill has received personal compensation in the range of $500-$4,999 for serving as a Consultant for KeifeRx. Dr. Shill has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Praxis Precision Medicine. Dr. Shill has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Fasikl Inc. Dr. Shill has received personal compensation in the range of $0-$499 for serving as a Consultant for Boston Scientific. Dr. Shill has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi Tanabe Pharma America.
Olavo Vasconcelos, MD No disclosure on file
Bahman Jabbari, MD, FAAN Dr. Jabbari has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Jabbari has received publishing royalties from a publication relating to health care.
Olga A. Prokhorenko, MD No disclosure on file
Nizar Souayah, MD, FAAN Dr. Souayah has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Takeda. Dr. Souayah has received publishing royalties from a publication relating to health care.
Sanjay Kalra, MD The institution of Dr. Kalra has received research support from Brain Canada Foundation. The institution of Dr. Kalra has received research support from Biogen.
John Wong No disclosure on file
Anna Miller No disclosure on file
John N. Caviness, MD, FAAN Dr. Caviness has nothing to disclose.
Erika Driver-Dunckley, MD, FAAN Dr. Driver-Dunckley has nothing to disclose.
Padma R. Mahant, MD No disclosure on file
Johan E. Samanta, MD No disclosure on file
Joseph Hentz No disclosure on file
Kenshi Terajima, MD, PhD No disclosure on file
Jerry R. Mendell, MD, FAAN Dr. Mendell has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vertex. Dr. Mendell has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Mendell has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sarepta Therapeutics . The institution of Dr. Mendell has received research support from Sarepta.
Samuel Goldman, MD, MPH Dr. Goldman has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Littlepage Booth Leckman. The institution of Dr. Goldman has received research support from Michael J Fox Foundation. The institution of Dr. Goldman has received research support from US Department of Defense. The institution of Dr. Goldman has received research support from US Veterans Administration. The institution of Dr. Goldman has received research support from National Institutes of Health. The institution of Dr. Goldman has received research support from Health Resources and Services Administration. The institution of Dr. Goldman has received research support from American Academy of Pediatrics. Dr. Goldman has received personal compensation in the range of $100,000-$499,999 for serving as a Professor with University of California San Francisco. Dr. Goldman has received personal compensation in the range of $100,000-$499,999 for serving as a Staff Physician with San Francisco Veterans Affairs Health Care System.
Caroline M. Tanner, MD, PhD, FAAN Dr. Tanner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Evidera. Dr. Tanner has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurocrine. Dr. Tanner has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jazz Pharmaceuticals/Cavion. Dr. Tanner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bial . Dr. Tanner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Supernus. Dr. Tanner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche Genentech. The institution of Dr. Tanner has received research support from Gateway LLC. The institution of Dr. Tanner has received research support from Roche\Genentech. The institution of Dr. Tanner has received research support from Michael J Fox Foundation . The institution of Dr. Tanner has received research support from National Institute of Health . The institution of Dr. Tanner has received research support from Department of Defense. Dr. Tanner has received personal compensation in the range of $500-$4,999 for serving as a Faculty, CME presentation with Medscape /WebND.
J W. Langston, MD No disclosure on file
Grace S. Bhudhikanok, PhD No disclosure on file
Anjali Gupta No disclosure on file
Amelia Ciofani No disclosure on file
Marika Hohol, MD Dr. Hohol has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Hohol has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Hohol has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Genzyme. Dr. Hohol has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Seronon. Dr. Hohol has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Hohol has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion Pharmaceuticals. Dr. Hohol has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Hohol has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for EMD Serono.
Adam Carpenter, MD An immediate family member of Dr. Carpenter has received personal compensation for serving as an employee of MarPam Pharma. The institution of Dr. Carpenter has received research support from Roche. The institution of Dr. Carpenter has received research support from Immune Tolerance Network. The institution of an immediate family member of Dr. Carpenter has received research support from NIH.
Suraj Muley, MD, FAAN Dr. Muley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. Muley has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Muley has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for CSL Behring. Dr. Muley has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Takeda. Dr. Muley has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Catalyst. Dr. Muley has received publishing royalties from a publication relating to health care.
Gary Birnbaum, MD, FAAN No disclosure on file
Afshin A. Divani, PhD The institution of Dr. Divani has received research support from Department of Defense.
Cynthia F. Barton No disclosure on file
Maggie Yin No disclosure on file
Maria C. Zurru, MD No disclosure on file
Edgardo Cristiano, MD Dr. Cristiano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Cristiano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Cristiano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Genzyme. Dr. Cristiano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Cristiano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck.
Ulrich Bogdahn, MD No disclosure on file
Juergen Winkler No disclosure on file
Frederick E. Munschauer III, MD, FAAN Dr. Munschauer has received personal compensation for serving as an employee of Emalex Biosciences. Dr. Munschauer has stock in Emalex Biosciences.
Neeta Garg, MD Dr. Garg has nothing to disclose.
Bianca Weinstock-Guttman, MD Dr. Weinstock-Guttman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Weinstock-Guttman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Weinstock-Guttman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis . Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genzyme &Sanofi. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen . Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Weinstock-Guttman has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Weinstock-Guttman has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Janssen. Dr. Weinstock-Guttman has received personal compensation in the range of $0-$499 for serving as a Reviewer with NIH.
Ajith Sominanda No disclosure on file
Jan A. Hillert, MD Dr. Hillert has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Hillert has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celgene. Dr. Hillert has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Hillert has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Hillert has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sandoz. Dr. Hillert has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. The institution of Dr. Hillert has received research support from Biogen. The institution of Dr. Hillert has received research support from Celgene. The institution of Dr. Hillert has received research support from Merck. The institution of Dr. Hillert has received research support from Novartis. The institution of Dr. Hillert has received research support from Sanofi. The institution of Dr. Hillert has received research support from Roche.
Maria Martinez-Lage, MD The institution of Dr. Martinez-Lage has received research support from NIH.
Antonio Bertolotto, MD, FAAN Dr. Bertolotto has nothing to disclose.
Marco Capobianco, MD No disclosure on file
Simona Malucchi No disclosure on file
Francesca Gilli No disclosure on file
Paul H. Gordon, MD, PhD, FAAN No disclosure on file
Paolo Girlanda No disclosure on file
Fortunato Battaglia, MD Dr. Battaglia has nothing to disclose.
Angelo Quartarone, MD No disclosure on file
Domenica Crupi No disclosure on file
Antonio Sant'Angelo, MD No disclosure on file
Joseph Herbert, MD No disclosure on file
Michele K. York, PhD, ABPP-CN Dr. York has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for RAD-PD. The institution of Dr. York has received research support from Michael J. Fox Foundation. The institution of Dr. York has received research support from NIH. The institution of Dr. York has received research support from Takeda.
Eugene C. Lai, MD, PhD, FAAN Dr. Lai has received publishing royalties from a publication relating to health care.
Stacy A. Rudnicki, MD, FAAN Dr. Rudnicki has received personal compensation for serving as an employee of Cytokinetics. Dr. Rudnicki has stock in Cytokinetics.
Alexandru C. Barboi, MD Dr. Barboi has nothing to disclose.
Safwan S. Jaradeh, MD, FAAN Dr. Jaradeh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alnylam. Dr. Jaradeh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Akcea. Dr. Jaradeh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alnylam & Akcea. The institution of Dr. Jaradeh has received research support from Alnylam.
William Bara-Jimenez, MD No disclosure on file
Alexandros Papadimitriou, MD No disclosure on file
Merle Diamond Merle Diamond has received personal compensation for serving as an employee of Diamond Headache Clinic. Merle Diamond has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal Pharmaceuticals. Merle Diamond has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AbbVie . Merle Diamond has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Impel Neuropharma. Merle Diamond has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva Pharmaceuticals. Merle Diamond has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Axsome Therapeutics. Merle Diamond has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AbbVie . Merle Diamond has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Axsome Therapeutics. Merle Diamond has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Impel Neuropharma. Merle Diamond has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amneal Pharmaceuticals'. Merle Diamond has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva Pharmaceuticals Industries Ltd. Merle Diamond has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Axsome Pharma. Merle Diamond has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for AbbVie . Merle Diamond has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Impel Neuropharma. Merle Diamond has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva Pharmautical Industries Ltd. Merle Diamond has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Lundbeck . Merle Diamond has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for National Headache Foundation .
Denis Bron No disclosure on file
David Johnson No disclosure on file
Benjamin R. Brooks, MD, FAAN Dr. Brooks has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Mitsubishi Tanabe Pharma America. Dr. Brooks has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Medicinova. Dr. Brooks has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Brooks has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AB Science. Dr. Brooks has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ionis. Dr. Brooks has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Mitsubishi Tanabe Pharma America. The institution of Dr. Brooks has received research support from Mitsubishi TanabePharma America. Dr. Brooks has received personal compensation in the range of $0-$499 for serving as a Member Annual Surveillance Committee CDC National ALS Registry with Center for Disease Control Agency Toxic Substances Disease Registry. Dr. Brooks has a non-compensated relationship as a Member ALS Quality Measures Subcommittee with 好色先生 that is relevant to AAN interests or activities.
Daniel J. Licht, MD No disclosure on file
Laura Herbelin No disclosure on file
Rodney Christensen No disclosure on file
John Tobin No disclosure on file
John Campbell No disclosure on file
Murali Ramanathan, PhD The institution of Dr. Ramanathan has received research support from DoD. Dr. Ramanathan has received publishing royalties from a publication relating to health care.
Bernhard Hemmer, MD No disclosure on file
Jayawant N. Mandrekar, PhD Dr. Mandrekar has nothing to disclose.
Nisha Chhabria, MD, FAAN No disclosure on file
Peter B. Forgacs, MD Dr. Forgacs has received personal compensation for serving as an employee of Xenon Pharmaceuticals. Dr. Forgacs has or had stock in Xenon Pharmaneuticals.
Joan Miravite, DNP, RN, FNP-BC, FAAN, FAANP, DAAN Dr. Miravite has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic. Dr. Miravite has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbott. Dr. Miravite has a non-compensated relationship as a Board Member with Association of Movement Disorder Advanced Practice Providers that is relevant to AAN interests or activities.
Sabine Cepok No disclosure on file
Gloria Von Geldern, MD, FAAN The institution of Dr. Von Geldern has received research support from Novartis. The institution of Dr. Von Geldern has received research support from Contineum Therapeutics. Dr. Von Geldern has received personal compensation in the range of $0-$499 for serving as a DSMB member with NIH, NINDS. Dr. Von Geldern has a non-compensated relationship as a editorial board member with MS and Related Disorders Journal that is relevant to AAN interests or activities.
Minas Tzagournissakis, MD No disclosure on file
Andreas J. Plaitakis, MD No disclosure on file
Richard A. Lewis, MD, FAAN Dr. Lewis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Argenx. Dr. Lewis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for CSL Behring. Dr. Lewis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Grifols. Dr. Lewis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Takeda. Dr. Lewis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Nuvig. Dr. Lewis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Dianthus. Dr. Lewis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Janssen. Dr. Lewis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Medscape. Dr. Lewis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Annexon. Dr. Lewis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Immunovant. Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BioCryst. Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NervoSave. Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Annexon. Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovant. Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TGTX. Dr. Lewis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Boehringer-Ingleheim. Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Intellia. Dr. Lewis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Cartesian. Dr. Lewis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for CME Outfitters. Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PeerVision. Dr. Lewis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Up to Date. Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Boehringer Ingelheim. Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alnylam. Dr. Lewis has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Intellia. Dr. Lewis has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Shernoff et al. Dr. Lewis has received publishing royalties from a publication relating to health care.
Lynn S. Ashby, MD Dr. Ashby has nothing to disclose.
Philippe Couratier, PhD Dr. Couratier has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Couratier has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Couratier has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier .
Guillermo Videla, MD No disclosure on file
Julie Phukan, MB, BCh, MRCPI No disclosure on file
Orna O'Toole, MB, BCh, BAO MD Dr. O'Toole has nothing to disclose.
Alain S. Maertens De Noordhout, MD, PhD No disclosure on file
Julien Cremers No disclosure on file
Valerie Delvaux, MD No disclosure on file
Tatiana Witjas No disclosure on file
Edward C. Smith, MD Dr. Smith has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Avidity Biosciences. Dr. Smith has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Solid Bioscences. Dr. Smith has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Catalyst.
James P. Wymer, MD, PhD, FAAN No disclosure on file
Wendy Frye No disclosure on file
Aziz I. Shaibani, MD, FAAN Dr. Shaibani has nothing to disclose.
James Berg No disclosure on file
Carl Granger No disclosure on file
Phyllis L. Koenig, PhD No disclosure on file
Herman Buschke, MD No disclosure on file
Charles B. Hall, PhD No disclosure on file
Seward B. Rutkove, MD, FAAN Dr. Rutkove has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Myolex, Inc. Dr. Rutkove has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Academy of Neuorlogy . The institution of Dr. Rutkove has received research support from NIH. The institution of Dr. Rutkove has received research support from NASA. The institution of Dr. Rutkove has received research support from Blavatnik Family Foundation. Dr. Rutkove has received intellectual property interests from a discovery or technology relating to health care. Dr. Rutkove has received intellectual property interests from a discovery or technology relating to health care. Dr. Rutkove has received publishing royalties from a publication relating to health care. Dr. Rutkove has received publishing royalties from a publication relating to health care. Dr. Rutkove has received personal compensation in the range of $500-$4,999 for serving as a Grant Reviewer with NIH.
Rajinder Singh, MD, MBBS, MRCP No disclosure on file
Robert A. Hauser, MD, MBA, FAAN Dr. Hauser has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Supernus. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Stoparkinson. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Revance. Dr. Hauser has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Abbvie. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurocrine. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi Tanabe. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amneal. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Intrance. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zambon. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for NanoPharmasolutions. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for HanAll BioPharma. Dr. Hauser has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Cerevance. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Clario. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for ABLi Therapeutics. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sumitomo. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Taurus Therapeutics. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sorriddi Therapeutics. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Contera. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lundbeck. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alterity Therapeutics. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Convatec Inc. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Knight Therapeutics. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Acadia. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biorasi. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medicure Pharma. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BlueRock. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Inhibikase. The institution of Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Stoparkinson. The institution of Dr. Hauser has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Photopharmics. The institution of Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ABLi Therapeutics. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amneal . Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Neurocrine Biosciences. Dr. Hauser has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for Supernus. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie. Dr. Hauser has or had stock in Inhibikase.Dr. Hauser has or had stock in Axial Therapeutics.Dr. Hauser has or had stock in Enterin.Dr. Hauser has or had stock in Photopharmics. The institution of Dr. Hauser has received research support from Annovis Bio, Inc.. The institution of Dr. Hauser has received research support from Inhibikase Therapeutics. The institution of Dr. Hauser has received research support from AbbVie, Inc.. The institution of Dr. Hauser has received research support from Biogen MA. The institution of Dr. Hauser has received research support from Cavion, Inc.. The institution of Dr. Hauser has received research support from Cerevance Beta, Inc.. The institution of Dr. Hauser has received research support from Cerevel Therapeutics. The institution of Dr. Hauser has received research support from Enterin, Inc.. The institution of Dr. Hauser has received research support from Genentech. The institution of Dr. Hauser has received research support from Global Kinetics Corporation. The institution of Dr. Hauser has received research support from Hoffman-La Roche Inc. The institution of Dr. Hauser has received research support from Michael J. Fox Foundation for Parkinson's Research. The institution of Dr. Hauser has received research support from National Parkinson's Foundation. The institution of Dr. Hauser has received research support from Neuroderm. The institution of Dr. Hauser has received research support from Sage Therapeutics. The institution of Dr. Hauser has received research support from Scion NeuroStim. The institution of Dr. Hauser has received research support from UCB BioPharma. The institution of Dr. Hauser has received research support from UCB. The institution of Dr. Hauser has received research support from Amneal Pharmaceuticals. The institution of Dr. Hauser has received research support from Motric Bio, Inc.. The institution of Dr. Hauser has received research support from Sun Pharma Advanced Research Company. The institution of Dr. Hauser has received research support from Teva Branded Pharmaceuticals. The institution of Dr. Hauser has received research support from Truebinding, Inc.. The institution of Dr. Hauser has received research support from Jazz Pharmaceuticals. The institution of Dr. Hauser has received research support from Ipsen. Dr. Hauser has received intellectual property interests from a discovery or technology relating to health care.
Stuart N. Hoffman, DO No disclosure on file
Jonathan P. Hosey, MD, FAAN Dr. Hosey has nothing to disclose.
Linda M. Famiglio, MD No disclosure on file
Mary Blosky No disclosure on file
Chitharanjan V. Rao, MD No disclosure on file
Linda Winfield, RN No disclosure on file
Seth L. Pullman, MD, FAAN No disclosure on file
Blair Ford, MD, FAAN No disclosure on file
Cynthia McRae, PhD No disclosure on file
Guy M. McKhann, MD No disclosure on file
Teodoro Del Ser Escribano, PhD No disclosure on file
Shyam Prabhakaran, MD Dr. Prabhakaran has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for University of Cincinnati. Dr. Prabhakaran has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for University of Cincinnati. The institution of Dr. Prabhakaran has received research support from NIH . The institution of Dr. Prabhakaran has received research support from AHRQ. Dr. Prabhakaran has received publishing royalties from a publication relating to health care.
Madhuri Behari, MD No disclosure on file
Sumit Singh, MD No disclosure on file
Edward J. Kasarskis, MD, PhD, FAAN The institution of Dr. Kasarskis has received research support from Healey Platform Trial Group. The institution of Dr. Kasarskis has received research support from Amylyx . The institution of Dr. Kasarskis has received research support from Alexion. The institution of Dr. Kasarskis has received research support from Woolsey . Dr. Kasarskis has a non-compensated relationship as a Director of ALSA-supported clinic at the University of Kentucky with ALS Association that is relevant to AAN interests or activities.
Marcia F. Rupnow, PhD No disclosure on file
Bassel W. Abou-Khalil, MD, FAAN The institution of Dr. Abou-Khalil has received research support from Cerevel. The institution of Dr. Abou-Khalil has received research support from Xenon. The institution of Dr. Abou-Khalil has received research support from Otsuka. The institution of Dr. Abou-Khalil has received research support from UCB. The institution of Dr. Abou-Khalil has received research support from SK LIfe Science. The institution of Dr. Abou-Khalil has received research support from Neuroelectrics.
Khalid A. Hassan, MD No disclosure on file
Elizabeth Loder, MD, MPH Dr. Loder has received personal compensation in the range of $5,000-$9,999 for serving as an officer or member of the Board of Directors for Headache Cooperative of New England. The institution of Dr. Loder has received personal compensation in the range of $100,000-$499,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for The BMJ.
Robert W. Kowalski No disclosure on file
Kurt T. Kreiter No disclosure on file
Elizabeth Raynor, MD No disclosure on file
Karin Woodman, MD Dr. Woodman has nothing to disclose.
Georgios Georgakakis No disclosure on file
Vasileios Mastorodemos, MD No disclosure on file
Klados Georgios, DO No disclosure on file
Kalliopi Psaroudaki, MD No disclosure on file
Aikaterini Kalamafkanaki No disclosure on file
Thomas Maris No disclosure on file
Cleanthe Spanaki, MD, PhD The institution of Dr. Spanaki has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PHARMABIDE/SPECIFAR-TEVA. The institution of Dr. Spanaki has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ALLERGAN. The institution of Dr. Spanaki has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. The institution of Dr. Spanaki has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MERCK SERONO. The institution of Dr. Spanaki has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for ITF. The institution of Dr. Spanaki has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for SPECIFAR/TEVA. The institution of Dr. Spanaki has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for ABBVIE. The institution of Dr. Spanaki has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for ABBVIE. The institution of Dr. Spanaki has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for SPECIFAR/TEVA. The institution of Dr. Spanaki has received research support from ABBVIE.
Gilberto Levy, MD No disclosure on file
Steven M. Albert, PhD, MSPH, FAAN No disclosure on file
Petra Kaufmann, MD, FAAN Dr. Kaufmann has received personal compensation for serving as an employee of Affinia Therapeutics. Dr. Kaufmann has received personal compensation for serving as an employee of Vigil Neuroscience. Dr. Kaufmann has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for DTx. Dr. Kaufmann has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Taysha Gene Therapies. Dr. Kaufmann has stock in Vigil Neuroscience. The institution of an immediate family member of Dr. Kaufmann has received research support from Cystic Fibrosis Foundation . Dr. Kaufmann has a non-compensated relationship as a Member of a Scientific Advisory Board with NIH that is relevant to AAN interests or activities.
Jacqueline Montes, PT, EdD, NCS Ms. Montes has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Ms. Montes has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for F. Hoffman LaRoche. Ms. Montes has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Scholar Rock. Ms. Montes has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. The institution of Ms. Montes has received research support from NIH/NICHD. The institution of Ms. Montes has received research support from Muscular Dystrophy Association. The institution of Ms. Montes has received research support from Cure SMA.
Richard Buchsbaum No disclosure on file
Dieter J. Meyerhoff No disclosure on file
Stefan Gazdzinski, PhD No disclosure on file
Timothy C. Durazzo, PhD No disclosure on file
Harrison C. Walker III, MD Dr. Walker has nothing to disclose.
Ray L. Watts, MD, FAAN No disclosure on file
Gerald J. Calegan, MD No disclosure on file
Barton Guthrie No disclosure on file
Agnes Supala- Berger, MD No disclosure on file
Raya Wehbeh, MD No disclosure on file
Meike Kasten, MD No disclosure on file
Valerie McGuire, PhD No disclosure on file
Anabel R. Chade, MD No disclosure on file
Lorene M. Nelson, PhD Dr. Nelson has nothing to disclose.
Rita A. Popat, PhD No disclosure on file
Raija Lindberg, MD No disclosure on file
Marco D'Amelio, MD No disclosure on file
Graziella Callari No disclosure on file
Paolo Ragonese No disclosure on file
Alfredo Thomson, MD Dr. Thomson has nothing to disclose.
Ricardo F. Allegri, MD, PhD, FAAN Dr. Allegri has nothing to disclose.
Raul L. Arizaga, MD, FAAN No disclosure on file
Carlos G. Abel, MD No disclosure on file
Cecilia Serrano No disclosure on file
Belen Viaggio No disclosure on file
Fernando Taragano No disclosure on file
Carole Dufouil, PhD No disclosure on file
Christophe Tzourio, MD, PhD No disclosure on file
Felix Schlachetzki, MD No disclosure on file
Sebastian A. Haas, MD No disclosure on file
Bernadette Boden-Albala, DrPH Ms. Boden-Albala has received research support from NIH.
Liliana B. Patrucco, MD Dr. Patrucco has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Dr. Patrucco has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Patrucco has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Novartis. Dr. Patrucco has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Biogen.
Marcelo F. Rugiero, MD No disclosure on file
Peter Vieregge, MD No disclosure on file
Yaakov Stern, PhD Dr. Stern has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Stern has received intellectual property interests from a discovery or technology relating to health care. Dr. Stern has received publishing royalties from a publication relating to health care.
Nikolaos Scarmeas, MD, FAAN Dr. Scarmeas has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Albert Einstein Collego of Medicine. The institution of Dr. Scarmeas has received research support from NovoNordisc. The institution of Dr. Scarmeas has received research support from European Union Horizon Projects. The institution of Dr. Scarmeas has received research support from Hellenic Foundation for Research & Innovation .
Joshua J. Gagne No disclosure on file
George Papadopoulos, BS No disclosure on file
Elena V. Simon, BA No disclosure on file
Majid Fotuhi, MD, PhD Dr. Fotuhi has nothing to disclose.
Kathleen A. Welsh-Bohmer No disclosure on file
Ara Khachaturian No disclosure on file
Constantine Lyketsos Constantine Lyketsos has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche, Avanir, Karuna, Maplight, Axsome, GW Research Limited, Merck, EXCIVA GmbH, Otsuka, IntraCellular Therapies, Medesis, BMS, IQVIA. Constantine Lyketsos has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for IQVIA. The institution of Constantine Lyketsos has received research support from NIA. Constantine Lyketsos has received publishing royalties from a publication relating to health care. Constantine Lyketsos has received publishing royalties from a publication relating to health care.
Ophelia Godin No disclosure on file
Michael L. Smith, PhD No disclosure on file
Ellen H. Grober, PhD No disclosure on file
Carolyn Winter-Rosenberg No disclosure on file
Darren P. Baker, PhD Dr. Baker has received personal compensation for serving as an employee of Sanofi. Dr. Baker has received stock or an ownership interest from Sanofi.
Deanna Saylor, MD, MHS Dr. Saylor has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for 好色先生. The institution of Dr. Saylor has received research support from National Institutes of Health. The institution of Dr. Saylor has received research support from 好色先生. Dr. Saylor has a non-compensated relationship as a Member of multiple committees and task forces focused on improving access to MS medications to people across the world with Multiple Sclerosis International Federation that is relevant to AAN interests or activities. Dr. Saylor has a non-compensated relationship as a Member of the Neurology and COVID19 committee with World Health Organization that is relevant to AAN interests or activities. Dr. Saylor has a non-compensated relationship as a Member of the International Outreach Committee, Junior and Early Career Membership Committee, and 好色先生al Innovation Commitees with American Neurological Association that is relevant to AAN interests or activities.
Kottil W. Rammohan, MD Dr. Rammohan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Rammohan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Rammohan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Rammohan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. Dr. Rammohan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genzyme. Dr. Rammohan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Serono. The institution of Dr. Rammohan has received research support from Genentech. The institution of Dr. Rammohan has received research support from Genzyme. The institution of Dr. Rammohan has received research support from EMD Serono. The institution of Dr. Rammohan has received research support from Alexion.
Deborah Gustafson, PhD No disclosure on file
Ruediger Kratz, MD, FAAN No disclosure on file
Tonette Gehrking Tonette Gehrking has nothing to disclose.
Pierre Labauge, MD Dr. Labauge has nothing to disclose.
Jean-Francois Dartigues, PhD No disclosure on file
Umesh K. Sharma, MD Dr. Sharma has nothing to disclose.
Edith Durso-DeCruz, PhD No disclosure on file
Russell K. Portenoy, MD No disclosure on file
Rachel Whitmer, PhD Dr. Whitmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech . Dr. Whitmer has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Alzheimer's and Dementia:Journal of the Alzheimer's Association . The institution of Dr. Whitmer has received research support from National. Institute of Health .
Robert G. Holloway, MD, MPH, FAAN Dr. Holloway has nothing to disclose.
Deborah M. Miller, PhD Dr. Miller has received intellectual property interests from a discovery or technology relating to health care.
Katia Noyes No disclosure on file
Martin Daumer, PhD No disclosure on file
Ilir Topalli No disclosure on file
Amir A. Touray, MBBS Dr. Touray has nothing to disclose.
David A. Bennett, MD Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Annovis. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for New Amsterdam. Dr. Bennett has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AbbVie. Dr. Bennett has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AbbVie.
Bakri Elsheikh, MD, FAAN Dr. Elsheikh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen . Dr. Elsheikh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argnex . The institution of Dr. Elsheikh has received research support from Biogen. The institution of Dr. Elsheikh has received research support from Cure SMA.
David Victorson, PhD No disclosure on file
William H. Frey II, PhD Dr. Frey has stock in IntrepiCyte, LLC. The institution of Dr. Frey has received research support from United States Department of Defense. Dr. Frey has received intellectual property interests from a discovery or technology relating to health care. Dr. Frey has received intellectual property interests from a discovery or technology relating to health care.
Cindy Nowinski, MD PhD The institution of Dr. Nowinski has received research support from National Institutes of Health.
Claudia Moy, PhD Claudia Moy, PhD has nothing to disclose.
Seth A. Kareus, MD, FAAN No disclosure on file
Randy Higashida, MD No disclosure on file
Michael Lawton, MD No disclosure on file
Lin Zhang, MD, PhD, FAAN Dr. Zhang has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for supernus. Dr. Zhang has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for supernus. The institution of Dr. Zhang has received research support from Michael J. Fox Foundation.
Peter Como, MD No disclosure on file
Ya Zhang No disclosure on file
Dorothea Altschul, MD An immediate family member of Dr. Altschul has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Microvention and stryker . Dr. Altschul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Siemens. The institution of Dr. Altschul has received research support from Max Kade .
Jeffrey Brown, PhD No disclosure on file
Bobbi Hopkins, MD No disclosure on file
Timothy E. Lotze, MD, FAAN Dr. Lotze has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Department of Justice VICP. The institution of Dr. Lotze has received research support from NIH. The institution of Dr. Lotze has received research support from National MS Society. The institution of Dr. Lotze has received research support from Sarepta Therapeutics. The institution of Dr. Lotze has received research support from PTC THERAPEUTICS. The institution of Dr. Lotze has received research support from Avexis. Dr. Lotze has received publishing royalties from a publication relating to health care. Dr. Lotze has received publishing royalties from a publication relating to health care.
Joseph Menzin, PhD No disclosure on file
Mark Friedman, DO Dr. Friedman has nothing to disclose.
Chitra Krishnan No disclosure on file
Michael W. Lenihan, MD No disclosure on file
David H. Snyder, MD No disclosure on file
Neil S. Lava, MD, FAAN No disclosure on file
Kara Patrick No disclosure on file
Cornelia Mihai, MD, FAAN Dr. Mihai has nothing to disclose.
Julia A. Cassetta, MD No disclosure on file
Alexander G. Khandji, MD No disclosure on file
Manuel M. Buitrago Blanco, MD, PhD No disclosure on file
Xin Liu No disclosure on file
Sean I. Savitz, MD Dr. Savitz has nothing to disclose.
C. W. Olanow, MD Dr. Olanow has received personal compensation for serving as an employee of Clintrex Research Corporation. Dr. Olanow has received personal compensation in the range of $1,000,000+ for serving as an officer or member of the Board of Directors for Clintrex Research Corporation. Dr. Olanow has received personal compensation in the range of $100,000-$499,999 for serving as an Expert Witness for Chevron/Syngenta. Dr. Olanow has stock in Clintrex Research Corporation.
Kala M. Mehta, DSc No disclosure on file
Brenda Kurland, PhD No disclosure on file
James L. Frey, MD, FAAN No disclosure on file
James R. Couch, Jr., MD, PhD, FAAN No disclosure on file
Thomas N. Chase, MD Dr. Chase has received personal compensation for serving as an employee of Chase Therapeutics Corporation. Dr. Chase has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Riverside Pharmaceuticals Corporation. Dr. Chase has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Chase Therapeutics Corporation. Dr. Chase has received stock or an ownership interest from Chase Therapeutics Corporation. Dr. Chase has received stock or an ownership interest from Riverside Pharmaceuticals Corporation.
James A. Mortimer, PhD, FAAN No disclosure on file
Robert P. Turner, MD, MSCR No disclosure on file
Susanne Schwalen, MD No disclosure on file
David M. Biondi, DO, FAAN Dr. Biondi has received personal compensation for serving as an employee of Cohen Veterans Bioscience, Inc. Dr. Biondi has received personal compensation for serving as an employee of Alder Biopharmaceuticals, Inc. Dr. Biondi has received stock or an ownership interest from Johnson & Johnson . The institution of Dr. Biondi has received research support from US Department of Defense .
Larry S. Ivanco No disclosure on file
Nicolaas I. Bohnen, MD, PhD, FAAN Dr. Bohnen has stock in Delta. The institution of Dr. Bohnen has received research support from NIH. The institution of Dr. Bohnen has received research support from VA. Dr. Bohnen has received research support from NIH. The institution of Dr. Bohnen has received research support from Parkinson fnd.
Mark Wainwright, MD, PhD, FAAN Dr. Wainwright has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sage Therapeutics.
Ahmad M. Al-Sabbagh, MD Dr. Al-Sabbagh has nothing to disclose.
Randy Bennett No disclosure on file
Katarzyna Sadowski, MD, PhD No disclosure on file
Maura Del Bene, RN, BSN No disclosure on file
Dana Ivanco No disclosure on file
Jorge Restrepo, MD No disclosure on file
Oscar G. Bernal, MD No disclosure on file
Federico Silva, MD No disclosure on file
Mauricio Rueda-Acevedo, MD No disclosure on file
Sandra E. Silva, MD No disclosure on file
Jorge Luis Orozco, MD No disclosure on file
German Enrique Perez Romero, MD No disclosure on file
Marilyn Albert Marilyn Albert has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Marilyn Albert has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Marilyn Albert has received personal compensation in the range of $500-$4,999 for serving as a Chair with Global Council on Brain Health.
Karen Bell, MD Dr. Bell has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. The institution of Dr. Bell has received research support from ACTC/NIA. Dr. Bell has received personal compensation in the range of $500-$4,999 for serving as a Shareholder with Novartis. Dr. Bell has received personal compensation in the range of $500-$4,999 for serving as a Shareholder with Johnson & Johnson. Dr. Bell has received personal compensation in the range of $5,000-$9,999 for serving as a Shareholder with Pfizer. Dr. Bell has received personal compensation in the range of $500-$4,999 for serving as a shareholder with Baxter International. Dr. Bell has received personal compensation in the range of $500-$4,999 for serving as a shareholder with Takeda. Dr. Bell has received personal compensation in the range of $500-$4,999 for serving as a shareholder with Cardinal Health.
Jason Brandt, PhD No disclosure on file
Leonard van den Berg, MD The institution of Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amylyx. The institution of Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ferrrer. The institution of Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. The institution of Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. The institution of Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. The institution of Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS. The institution of Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ArgenX. The institution of Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Projenx. Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Corcept. The institution of Dr. Van den Berg has received research support from Netherlands ALS Foundation.
Warren E. Lux, Jr., MD, FAAN No disclosure on file
Karen A. Schwab No disclosure on file
Nina Dronkers, PhD The institution of Dr. Dronkers has received research support from NIH. Dr. Dronkers has received publishing royalties from a publication relating to health care. Dr. Dronkers has received personal compensation in the range of $0-$499 for serving as a grants reviewer with NIH.
Gustavo J. Rodriguez, MD Dr. Rodriguez has nothing to disclose.
Teresa Griesing, PhD No disclosure on file
Yoshio Tsuboi, MD Dr. Tsuboi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eisai Co., Ltd.,. Dr. Tsuboi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Takeda Pharmaceutical Co., Ltd.,. Dr. Tsuboi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sumitomo Dainippon Pharma Co., Ltd.. Dr. Tsuboi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AbbVie GK,. Dr. Tsuboi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Otsuka Pharmaceutical Co., Ltd.. Dr. Tsuboi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kyowa Kirin Co., Ltd.. The institution of Dr. Tsuboi has received research support from Nipro Corporation.
Yasuhiko Baba, MD, PhD No disclosure on file
Serena Amici, MD No disclosure on file
Ju-Hun Lee, MD No disclosure on file
Soo-Jin Cho, MD No disclosure on file
Salvador Cruz-Flores, MD, FAAN The institution of Dr. Cruz-Flores has received research support from University of Texas System.
Wolfgang Singer, MD, FAAN Dr. Singer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven. The institution of Dr. Singer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Singer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ionis. Dr. Singer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Yoda. Dr. Singer has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Theravance. Dr. Singer has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ferrer. The institution of Dr. Singer has received research support from NIH. The institution of Dr. Singer has received research support from FDA. The institution of Dr. Singer has received research support from Michael J. Fox Foundation. Dr. Singer has received intellectual property interests from a discovery or technology relating to health care.
Gerard Besson No disclosure on file
Natasha Morozova No disclosure on file
Mauro Roberto Piovezan, MD No disclosure on file
Ju-Hong Min, MD No disclosure on file
Cyrus K. Dastur, MD Dr. Dastur has nothing to disclose.
Kwang H. Lee, MD No disclosure on file
Susanne Ostrowitzki, MD, PhD No disclosure on file
Yama Akbari, MD, PhD Dr. Akbari has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for AZ Injury Law. The institution of Dr. Akbari has received research support from NIH. The institution of Dr. Akbari has received research support from Hamamatsu Photonics KK. Dr. Akbari has received intellectual property interests from a discovery or technology relating to health care.
Manuel D. Flores, MD No disclosure on file
Dileep R. Yavagal, MD, FAAN Dr. Yavagal has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vascular Dynamics. Dr. Yavagal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Guidepoint. The institution of Dr. Yavagal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GLG. Dr. Yavagal has received personal compensation in the range of $0-$499 for serving as a Consultant for Medtronic. Dr. Yavagal has received personal compensation in the range of $0-$499 for serving as a Consultant for Cerenovus/Johnson & Johnson. Dr. Yavagal has received personal compensation in the range of $0-$499 for serving as a Consultant for Stryker. Dr. Yavagal has received personal compensation in the range of $0-$499 for serving as a Consultant for Poseydon. Dr. Yavagal has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Athersys. Dr. Yavagal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gravity Medical Technology. Dr. Yavagal has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Poseydon. Dr. Yavagal has stock in Poseydon. Dr. Yavagal has stock in Galaxy Therapeutics. Dr. Yavagal has stock in Stentrode. Dr. Yavagal has stock in Gravity Medical. Dr. Yavagal has stock in Gravity Medical Technology. Dr. Yavagal has stock in Athersys. Dr. Yavagal has stock in Rapid Medical . Dr. Yavagal has received intellectual property interests from a discovery or technology relating to health care. Dr. Yavagal has received personal compensation in the range of $5,000-$9,999 for serving as a Medicolegal Expert with Royal Carribean Cruise Line. Dr. Yavagal has received personal compensation in the range of $5,000-$9,999 for serving as a Medicolegal Consultant with Carnival Cruise Line.
Katherine Esse, MD No disclosure on file
Atif Zafar, MD Dr. Zafar has nothing to disclose.
Samuel J. Maiser, MD Dr. Maiser has nothing to disclose.
Yael Reijmer No disclosure on file
Ole Suhr The institution of Ole Suhr has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alnylam . The institution of Ole Suhr has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Akcea. The institution of Ole Suhr has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Prothena. The institution of Ole Suhr has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Intellia. The institution of Ole Suhr has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Akces. The institution of Ole Suhr has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alnylam. Ole Suhr has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alnylam. Ole Suhr has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Akcea. The institution of Ole Suhr has received research support from Swedish Heart and Lung Foundation.
Matthew Maas, MD, FAAN The institution of Dr. Maas has received research support from National Institutes of Health.
Joni M. Clark, MD No disclosure on file
Noel Carlson, PhD The institution of Mr. Carlson has received research support from Biogen. Mr. Carlson has received personal compensation in the range of $100,000-$499,999 for serving as a Employee as a Researcher with Veteran Affairs.
Melvin D. Wichter, MD No disclosure on file
Haralambos Alexopoulos No disclosure on file
Pavan Bhargava, MD, FAAN The institution of Dr. Bhargava has received research support from EMD Serono. The institution of Dr. Bhargava has received research support from Amylyx pharmaceuticals. The institution of Dr. Bhargava has received research support from Genentech. The institution of Dr. Bhargava has received research support from GSK.
Jose Luis Etcheverry, MD No disclosure on file
Moises Garces, MD No disclosure on file
Wei Ping Kay Ng, MD Dr. Ng has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Astra Zeneca.
Daniel Antoniello, MD Dr. Antoniello has nothing to disclose.
David M. Sletten, MBA Mr. Sletten has nothing to disclose.
James Guth, MD No disclosure on file
Ana Belen Caminero Rodriguez, MD Dr. Caminero Rodriguez has nothing to disclose.
Gabriel Persi Gabriel Persi has nothing to disclose.
Harry Alexopoulos No disclosure on file
Charles W. Brock, MD No disclosure on file
Nicholas B. Galifianakis, MD Dr. Galifianakis has nothing to disclose.
Maria Del Mar Mendibe Bilbao No disclosure on file
Rick Falzone No disclosure on file
Eric Liotta, MD Dr. Liotta has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Penumbra. The institution of Dr. Liotta has received research support from NIH-NINDS.
Pablo Davila Gonzalez No disclosure on file
Anne D. Yacoub, MD Dr. Yacoub has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AbbVie.
Raghav Govindarajan, MD, FAAN Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MT pharma. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Catalyst. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche . Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amicus. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Govindarajan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for MT pharma . Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Catalyst. Dr. Govindarajan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Argenx. Dr. Govindarajan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biohaven. Dr. Govindarajan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UCB. Dr. Govindarajan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Takeda. Dr. Govindarajan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Abbvie. The institution of Dr. Govindarajan has received research support from Band of Hope . The institution of Dr. Govindarajan has received research support from Alexion. Dr. Govindarajan has received publishing royalties from a publication relating to health care.
Aiden Haghikia, MD Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck Serono. The institution of Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Galapagos. Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck Serono. Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Kyverna. Dr. Haghikia has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Roche. Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Janssen. Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bayer. Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neuraxpharm. Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving as a speaker with Biogen. Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving as a speaker with Sanofi. Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving as a speaker with Novartis. Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving as a speaker with Merck Serono. Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving as a speaker with Celgene.
Leopold J. Streletz, MD, FAAN No disclosure on file
Michael Sidel, MD No disclosure on file
Bryan T. Klassen, MD The institution of Dr. Klassen has received research support from Insightec.
Muhammad Taimur A. Malik, MD Dr. Malik has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genetech . Dr. Malik has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jansen . Dr. Malik has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD serono. The institution of Dr. Malik has received research support from National MS Society .
Sarah S. Wang, PhD Dr. Wang has nothing to disclose.
Cynthia Gonzalez, MD Dr. Gonzalez has nothing to disclose.
Sarah G. Finnegan, MD, PhD No disclosure on file
Amy W. Jensen, RN, BSN No disclosure on file
Kristin Schwab No disclosure on file
Javier Jose Mallada No disclosure on file
Martin K. Nicholas, MD No disclosure on file
Emil Gaitour, MD No disclosure on file
Ayhan Ozturk, MD No disclosure on file
Karine Garneau, MD No disclosure on file
Sofia Akrivou No disclosure on file
Juan Parada, MD No disclosure on file
Pruthu P. Patel, MD No disclosure on file
Toru Kishitani, MD No disclosure on file
M. M. Paz Soldan, MD, PhD Dr. Paz Soldan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. The institution of Dr. Paz Soldan has received research support from National Institutes of Health. The institution of Dr. Paz Soldan has received research support from National Multiple Sclerosis Society. The institution of Dr. Paz Soldan has received research support from Western Institute for Biomedical Research. The institution of Dr. Paz Soldan has received research support from Biogen. The institution of Dr. Paz Soldan has received research support from Novartis. The institution of Dr. Paz Soldan has received research support from Clene Nanomedicine.
Glynnis Zieman, MD, MPH, FAAN Dr. Zieman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for National Football League.
Nancy B. Isenberg, MD, MPH, FAAN No disclosure on file
Turgut Tatlisumak, MD No disclosure on file
Leonard L. Yeo, MBBS The institution of Dr. Yeo has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Astrazeneca. The institution of Dr. Yeo has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for stryker. Dr. Yeo has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for NUHS. Dr. Yeo has received stock or an ownership interest from cereflo. The institution of Dr. Yeo has received research support from NMRC.
R. C. Gurses, MD No disclosure on file
Artem Kaplan, MD, PhD No disclosure on file
Roy C. NG No disclosure on file
Syeda L. Alqadri, MD No disclosure on file
Giacomo Comi Giacomo Comi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Giacomo Comi has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis.
Paisith Piriyawat, MD Dr. Piriyawat has nothing to disclose.
Judd M. Jensen, MD Dr. Jensen has nothing to disclose.
Jade Gehrking Jade Gehrking has nothing to disclose.
Sang Won Han No disclosure on file
Henrik Zetterberg Henrik Zetterberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie, Acumen, Alector, Alzinova, ALZpath, Amylyx, Annexon, Apellis, Artery Therapeutics, AZTherapies, Cognito Therapeutics, CogRx, Denali, Eisai, LabCorp, Merry Life, Nervgen, Novo Nordisk, Optoceutics, Passage Bio, Pinteon Therapeutics, Prothena, Quanterix, Red Abbey Labs, reMYND, Roche, Samumed, Siemens Healthineers, Triplet Therapeutics, and Wave. Henrik Zetterberg has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alzecure, BioArctic, Biogen, Cellectricon, Fujirebio, Lilly, Novo Nordisk, Roche, and WebMD. Henrik Zetterberg has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wiley and Elsevier. Henrik Zetterberg has stock in Brain Biomarker Solutions.
Anand Viswanathan, MD Dr. Viswanathan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alnylam Pharmaceuticals. Dr. Viswanathan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Viswanathan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche Pharmaceuticals.
David Bargiela, MD, PhD No disclosure on file
Brandon Francis, MD Dr. Francis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sunovian. Dr. Francis has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Montgomery and Associates.
Steven M. Greenberg, MD, PhD, FAAN Dr. Greenberg has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bayer. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squib. The institution of Dr. Greenberg has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alnylam. Dr. Greenberg has received research support from National Institutes of Health. Dr. Greenberg has received publishing royalties from a publication relating to health care.
Barry Byrne Barry Byrne has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. Barry Byrne has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Rocket Pharma. Barry Byrne has received personal compensation in the range of $5,000-$9,999 for serving as an officer or member of the Board of Directors for Muscular Dystrophy Association.
Glen A. Cook, Jr., MD, FAAN Dr. Cook has stock in Aspire Biopharma. An immediate family member of Dr. Cook has stock in Aspire Biopharma.
Omar Jawdat, MD Dr. Jawdat has nothing to disclose.
Santiago Pigretti No disclosure on file
Omar A. Alsinaidi, MD Dr. Alsinaidi has nothing to disclose.
Christine Schuhmann No disclosure on file
Patrizia Casaccia, MD, PhD No disclosure on file
Nicholas D. Schiff, MD Dr. Schiff has received publishing royalties from a publication relating to health care. Dr. Schiff has received personal compensation in the range of $500-$4,999 for serving as a study section member with NIH. Dr. Schiff has a non-compensated relationship as a Guidelines Panel Member with AAN that is relevant to AAN interests or activities.
Sarah A. Morrow, MD, MSC, FRCPC, FAAN Dr. Morrow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono/Merck. Dr. Morrow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celgene. Dr. Morrow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Morrow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Morrow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SanofiGenzyme. Dr. Morrow has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen Idec. Dr. Morrow has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Novartis. Dr. Morrow has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Roche. The institution of Dr. Morrow has received research support from Celgene. The institution of Dr. Morrow has received research support from SanofiGenzyme. The institution of Dr. Morrow has received research support from Novartis.
Jared Gollob, MD No disclosure on file
Osamu Watanabe, MD No disclosure on file
Sabrina Esposito No disclosure on file
Jorge L. Marcos, MD No disclosure on file
Daniel Martinez-Ramirez, MD Dr. Martinez-Ramirez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Mexico. Dr. Martinez-Ramirez has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbott Mexico.
John Vissing, MD Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dyne Therapeutics. Prof. Vissing has received personal compensation in the range of $0-$499 for serving as a Consultant for Denali Therapeutics. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amicus therapeutics. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avidity Therapeutics. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Italfarmaco. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sarepta. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NMD Pharma. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NMD Pharma. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avidity. Prof. Vissing has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sarepta. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion Pharmaceuticals. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Johnson & Johnson (Janssen). Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Edgewise Therapeutics. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB. The institution of Prof. Vissing has received research support from Rigshospitalet. The institution of Prof. Vissing has received research support from Avidity. The institution of Prof. Vissing has received research support from Sanofi. The institution of Prof. Vissing has received research support from Roche. The institution of Prof. Vissing has received research support from AnnJi.
Addie Patterson, DO Dr. Patterson has received personal compensation in the range of $500-$4,999 for serving as a Content creator with Medical insights group.
Claude J. Desnuelle, MD No disclosure on file
Paula Rauschkolb, DO No disclosure on file
Ashish Kulhari, MD No disclosure on file
Katelyn S. Kavak Ms. Kavak has nothing to disclose.
Mohammad S. Alangari, MD, FAAN No disclosure on file
Neha Prakash, MD The institution of Dr. Prakash has received research support from UCB Biosciences Inc.. The institution of Dr. Prakash has received research support from Parkinson Foundation.
Edip M. Gurol, MD The institution of Dr. Gurol has received research support from NIH/NINDS. The institution of Dr. Gurol has received research support from Boston Scientific Corporation. The institution of Dr. Gurol has received research support from AVID (a wholly owned subsidiary of Eli Lilly). The institution of Dr. Gurol has received research support from Pfizer.
Rajesh K. Sadasivuni, MD No disclosure on file
Tiffany Cossey, MD Dr. Cossey has nothing to disclose.
Serena Spudich, MD The institution of Dr. Spudich has received research support from NIH.
Eliahu S. Feen, MD No disclosure on file
Alberto Maud, MD Dr. Maud has nothing to disclose.
Xavier Ayrignac Xavier Ayrignac has nothing to disclose.
Jeffrey Statland, MD Dr. Statland has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arrowhead. Dr. Statland has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ML Bio. Dr. Statland has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Epic Bio. Dr. Statland has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Armatus . Dr. Statland has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kate Therapeutics. Dr. Statland has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vita Therapeutics. Dr. Statland has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Dyne Therapeutics. Dr. Statland has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avidity . Dr. Statland has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Fulcrum Therapeutics. Dr. Statland has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Statland has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Vertex . The institution of Dr. Statland has received research support from NIH. The institution of Dr. Statland has received research support from FSHD Society. The institution of Dr. Statland has received research support from Friends of FSH Research. The institution of Dr. Statland has received research support from FSHD Canada. The institution of Dr. Statland has received research support from MDA.
Corey McMillan, PhD Dr. McMillan has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. The institution of Dr. McMillan has received research support from Biogen. The institution of Dr. McMillan has received research support from NIH.
Ronald Davis, MD No disclosure on file
David Irwin, MD The institution of Dr. Irwin has received research support from NIH. The institution of Dr. Irwin has received research support from Prevail. The institution of Dr. Irwin has received research support from Passage Bio. The institution of Dr. Irwin has received research support from Alector. The institution of Dr. Irwin has received research support from Transposon. The institution of Dr. Irwin has received research support from Denali. The institution of Dr. Irwin has received research support from Cervo Med.
Hormozd Bozorgchami, MD No disclosure on file
Anhar Hassan, MBBCH, FRACP, FRCPI, FAAN The institution of Dr. Hassan has received research support from Intrabio . Dr. Hassan has received personal compensation in the range of $500-$4,999 for serving as a Invited speaker with Korean Movement Disorders Society.
Elizabeth A. Coon, MD, FAAN Dr. Coon has received publishing royalties from a publication relating to health care. Dr. Coon has a non-compensated relationship as a Non-Voting Member of the Board of Directors with UCNS that is relevant to AAN interests or activities.
Pei'En Fan, MD No disclosure on file
Shannon M. DiCarlo, MD, FAAN Dr. DiCarlo has nothing to disclose.
Kathleen Healey, PhD, NP No disclosure on file
Ellen Valadez, MD No disclosure on file
Joseph Y. Matsumoto, MD Dr. Matsumoto has nothing to disclose.
Idanis Berrios Morales, MD Dr. Berrios Morales has nothing to disclose.
Larry R. Faulkner, MD Dr. Faulkner has received personal compensation for serving as an employee of ABPN.
Ramsey A. Falconer, MD, FAAN Dr. Falconer has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Abbott. Dr. Falconer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Dr. Falconer has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Amneal. Dr. Falconer has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for GE Health. Dr. Falconer has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Acorda. Dr. Falconer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Kyowa Kirin. Dr. Falconer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurocrine. Dr. Falconer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Supernus. Dr. Falconer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sunovion. Dr. Falconer has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Federal Trade Comission (FTC). Dr. Falconer has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Justice Department.
Ariel Luzzi No disclosure on file
Zubair Ahmed, MD Dr. Ahmed has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eli Lilly. Dr. Ahmed has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie. Dr. Ahmed has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biohaven.
Yasar A. Torres-Yaghi, MD Dr. Torres-Yaghi has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Acorda. Dr. Torres-Yaghi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. Dr. Torres-Yaghi has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amneal. Dr. Torres-Yaghi has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Abbott. Dr. Torres-Yaghi has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Kyowa Kirin. Dr. Torres-Yaghi has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Teva. Dr. Torres-Yaghi has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sunovion .
Dharani Mudugal, MD No disclosure on file
Brajesh K. Lal Brajesh K. Lal has nothing to disclose.
Amanda Jagolino-Cole, MD, FAAN Dr. Jagolino-Cole has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for 好色先生 - Neurology Clinical Practice Journal. .
Nisha S. Bhatia, MD No disclosure on file
David Bar-Or David Bar-Or has received intellectual property interests from a discovery or technology relating to health care.
Nerses Bebek, MD, PhD Dr. Bebek has nothing to disclose.
Ovais Inamullah, MD Dr. Inamullah has nothing to disclose.
Krithiga Sekar, MD, PhD No disclosure on file
Jenifer Voeks Jenifer Voeks has nothing to disclose.
Nirali Vora, MD Dr. Vora has nothing to disclose.
Clarisse Carra-Dalliere No disclosure on file
Shima Bozorgui, MD Dr. Bozorgui has nothing to disclose.
Antreas Charidimou, MD, PhD MSc Dr. Charidimou has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Imperative Care. Dr. Charidimou has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier, Journal of Neurological Sciences.
Sean Rogers, MD, PhD No disclosure on file
Omar Al-Louzi, MD The institution of Dr. Al-Louzi has received research support from the National Multiple Sclerosis Society and American Brain Foundation. The institution of Dr. Al-Louzi has received research support from the Department of Defense.
Charbel E. Moussa, PhD, MB Dr. Moussa has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for KeifeRX LLC. Dr. Moussa has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sun Pharmaceuticals Research Industry. Dr. Moussa has received stock or an ownership interest from Orphan Therapeutics. The institution of Dr. Moussa has received research support from NIA. The institution of Dr. Moussa has received research support from Sun Pharmaceuticals Research Industry. The institution of Dr. Moussa has received research support from Alzheimer's Association . Dr. Moussa has received intellectual property interests from a discovery or technology relating to health care. Dr. Moussa has received intellectual property interests from a discovery or technology relating to health care. Dr. Moussa has received publishing royalties from a publication relating to health care. Dr. Moussa has received personal compensation in the range of $500-$4,999 for serving as a Grant reviewer with DG Information Technology. Dr. Moussa has received personal compensation in the range of $0-$499 for serving as a Peer Reviews with National Institutes of Health.
Elizabeth Gerard, MD Dr. Gerard has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Xenon. The institution of Dr. Gerard has received research support from NIH/NINDS. The institution of Dr. Gerard has received research support from Xenon Pharmaceuticals. The institution of an immediate family member of Dr. Gerard has received research support from NIH. The institution of Dr. Gerard has received research support from Eisai, Inc. (via Stanford University). Dr. Gerard has received publishing royalties from a publication relating to health care.
Reversa R. Mills-Joseph, MD Dr. Mills has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kyowa Kirin, Inc. Dr. Mills has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie.
Kaye E. Sedarsky, MD Dr. Sedarsky has nothing to disclose.
Christen Kutz No disclosure on file
Jessie Huisinga No disclosure on file
Kwan Ng, MD, PhD Dr. Ng has nothing to disclose.
Marcelo Mattiazzi, MD No disclosure on file
Kunakorn Atchaneeyasakul, MD No disclosure on file
Allison Lindauer, PhD, APRN The institution of Dr. Lindauer has received research support from National Institute on Aging. The institution of Dr. Lindauer has received research support from National Institute on Aging.
Asma Malik, MD Dr. Malik has nothing to disclose.
Sunhee Kim, MD No disclosure on file
Luis Guada-Delgado, MD Dr. Guada-Delgado has nothing to disclose.
Emil Ljungberg No disclosure on file
Somayyeh S. Sabet, MD No disclosure on file
William Curley, MD William Curley has nothing to disclose.
Leonid Groysman, MD The institution of Dr. Groysman has received research support from Celularity, Inc.
Duangnapa Roongpiboonsopit, MD No disclosure on file
Nicholas Vitanza No disclosure on file
Robert Paul, MD, PhD Dr. Paul has received personal compensation for serving as an employee of Alector. Dr. Paul has received stock or an ownership interest from Alector.
William Cho No disclosure on file
Tapan Mehta, MD Dr. Mehta has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Balt, Medtronic, J&J, Terumo.
Farhaan S. Vahidy, MBBS, PhD Dr. Vahidy has nothing to disclose.
Gyeong Seon Choi, MD No disclosure on file
Omer R. Khayali, MD No disclosure on file
Jerome De Seze Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma. Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma. Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma. Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma. Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma. Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma. Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma. Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma.
Jeffrey S. Phillips, PhD No disclosure on file
Kevin N. Ramdas, MD No disclosure on file
Candace B. Borders, MD Dr. Borders has nothing to disclose.
Julia Button No disclosure on file
Maureen E. Erwin No disclosure on file
Lisa Eunyoung Lee Lisa Eunyoung Lee has nothing to disclose.
Jan Leonard No disclosure on file
Kyong Jin Shin, MD No disclosure on file
Alireza Bozorgi, MD No disclosure on file
Sarah Hermanson, DNP, ARNP No disclosure on file
Penny D. McQueen No disclosure on file
Dinesh V. Jillella, MD Dr. Jillella has nothing to disclose.
Angie Richmond No disclosure on file
Ezgi Tiryaki, MD, FAAN Dr. Tiryaki has or had stock in HITIT Leadership Coaching.Dr. Tiryaki has a non-compensated relationship as a Professor of Neurology with University of Minnesota that is relevant to AAN interests or activities. Dr. Tiryaki has a non-compensated relationship as a Clinic Director of a Center of Excellence with The ALS Association that is relevant to AAN interests or activities. Dr. Tiryaki has a non-compensated relationship as a Volunteer Clinical Neurologist at ALS Clinic with Minneapolis VA Healthcare System that is relevant to AAN interests or activities.
Ihtesham Qureshi, MD No disclosure on file
Tania Garcia No disclosure on file
Jasvinder K. Atwal, PhD No disclosure on file
Ilya Nasrallah, MD, PhD Dr. Nasrallah has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai. Dr. Nasrallah has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Dr. Nasrallah has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer. Dr. Nasrallah has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Cassiday Schade LLP. The institution of Dr. Nasrallah has received research support from NIH. The institution of Dr. Nasrallah has received research support from ASNR.
Leila Parand, MD Dr. Parand has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eli Lily. Dr. Parand has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Esai. Dr. Parand has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Peer view . Dr. Parand has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Speaker Bureau .
Michael Rabbia No disclosure on file
Ilana B. Katz Sand, MD The institution of Dr. Katz Sand has received research support from National Multiple Sclerosis Society. The institution of Dr. Katz Sand has received research support from Hirschl Foundation. The institution of Dr. Katz Sand has received research support from National Institutes of Health. Dr. Katz Sand has received personal compensation in the range of $500-$4,999 for serving as a Conference presenter with 好色先生.
Carlos Lopez Gomez, PhD No disclosure on file
David A. Wolk, MD, FAAN Dr. Wolk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Wolk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Functional Neuromodulation. Dr. Wolk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for GSK. The institution of Dr. Wolk has received research support from Biogen. Dr. Wolk has received publishing royalties from a publication relating to health care. Dr. Wolk has received personal compensation in the range of $5,000-$9,999 for serving as a CME speaker with Eli Lilly.
Florian Ottenlinger No disclosure on file
Smit D. Patel, MD, MPH Dr. Patel has nothing to disclose.
Allan Dietz No disclosure on file
Carlos Gonzalez-Uscanga No disclosure on file
Reina Fuji No disclosure on file
Amal Al-Lozi No disclosure on file
Jillian Smith Jillian Smith has received personal compensation for serving as an employee of Roche Products Ltd. Jillian Smith has stock in Roche Holdings. Jillian Smith has received intellectual property interests from a discovery or technology relating to health care.
Diane Teagarden, NP Ms. Teagarden has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for livaNova. Ms. Teagarden has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neuropace.
Marco Pasi No disclosure on file
Ruslan Manashirov, MD No disclosure on file
Elizabeth A. Kichula, MD, PhD No disclosure on file
Eric Hirsch No disclosure on file
Amita Sehgal, PhD The institution of Dr. Sehgal has received research support from Howard Hughes Medical Institute. Dr. Sehgal has received personal compensation in the range of $10,000-$49,999 for serving as a Advisor with Leon Levy Foundation.
Ikram W. Khan, MD No disclosure on file
Ranier G. Reyes, MD Dr. Reyes has nothing to disclose.
Cristopher J. Kaps, MD No disclosure on file
Michael J. Morris, MB No disclosure on file
Khalid Al Sherbini, MD Dr. Al Sherbini has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for ceribell . Dr. Al Sherbini has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB.
Syeda Maria Muzammil, MD Dr. Muzammil has nothing to disclose.
Farhat Husain, MD Dr. Husain has nothing to disclose.
Kevin A. Yeboah, MD No disclosure on file
Batya Radzik, BSN No disclosure on file
Syeda Dania Shujaat, MD, MBBS No disclosure on file
Sam S. Handshoe Dr. Handshoe has nothing to disclose.
Jason Chang, MD Dr. Chang has nothing to disclose.
Talal Aboud, MD No disclosure on file
Salvador Vazquez No disclosure on file
Barbara Santos, MD No disclosure on file
Krishna Kandregula, MD No disclosure on file
Roland Wiest, MD No disclosure on file
Eva K. Ritzl, MD, MBA, FRCP (Glasgow), FAAN Dr. Ritzl has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for various law firms. Dr. Ritzl has a non-compensated relationship as a Advocacy committee co-chair and CPT and RUC representation with ACNS that is relevant to AAN interests or activities. Dr. Ritzl has a non-compensated relationship as a Health Policy committee member with AAN that is relevant to AAN interests or activities. Dr. Ritzl has a non-compensated relationship as a AAN HOD Alternate Delegate with AAN that is relevant to AAN interests or activities. Dr. Ritzl has a non-compensated relationship as a Epic Neurosciences steering board with Epic that is relevant to AAN interests or activities.
Avi Setton, MD No disclosure on file
Kushal Naik No disclosure on file
Rashi K. Krishnan, MD No disclosure on file
Uzoamaka Flake, MD No disclosure on file
Wendy C. Ziai, MD Dr. Ziai has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer. Dr. Ziai has received research support from NIH. Dr. Ziai has received publishing royalties from a publication relating to health care. Dr. Ziai has received personal compensation in the range of $500-$4,999 for serving as a Consultant with DOJ.
Trevor Moravec, MD No disclosure on file
Jonathan Santoro, MD Dr. Santoro has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Santoro has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Cycle Pharma. Dr. Santoro has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dianthus. Dr. Santoro has received personal compensation in the range of $500-$4,999 for serving as a Consultant for National Down Syndrome Society.
Christopher Skinner, MD, FRCPC No disclosure on file
Elliott Salamon, DO No disclosure on file
Andres De Leon, MD Dr. De Leon Benedetti has nothing to disclose.
Jacob Didion, MD No disclosure on file
David L. Camenga, MD, FAAN No disclosure on file
Jazmin G. Sotelo-Hernandez, MD No disclosure on file
Mark Rich, MD No disclosure on file
Alejandra Duque Ramirez, MD Dr. Duque Ramirez has nothing to disclose.
Kamilla D. Fernandez, MD No disclosure on file
Jorge Patiño No disclosure on file
Steven J. Kittner, MD, MPH The institution of Dr. Kittner has received research support from NINDS.
Susan Matesanz, MD Dr. Matesanz has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Matesanz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Matesanz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Atamyo . The institution of Dr. Matesanz has received research support from Sarepta . The institution of Dr. Matesanz has received research support from Pfizer. The institution of Dr. Matesanz has received research support from Genentech/Roche.
David Greer, MD No disclosure on file
Jacques M. Reynolds, DO No disclosure on file
Ilana Lasner, DO No disclosure on file
Julien Cavanagh, MD Dr. Cavanagh has nothing to disclose.
Boris Gutman No disclosure on file
David Post, MD Dr. Post has nothing to disclose.
Chad Oh Chad Oh has nothing to disclose.
Jordan Broman-Fulks, MD No disclosure on file
Julian D. Sanchez-Bautista No disclosure on file
Kimberly Geronimo No disclosure on file
Nathan S. Farkas, MD No disclosure on file
Nicole Heinl No disclosure on file
Sarah E. Mancone, MD No disclosure on file
Varsha Prabhakar, BA No disclosure on file
Matthew L. Morton, MD Dr. Morton has nothing to disclose.
Ayesha Naeem, MD, MBBS No disclosure on file
Katrina Geannopoulos, MD No disclosure on file
Shyam Panchal, MD No disclosure on file
Joy Z. Ding, MD No disclosure on file
Christopher B. Traner, MD Dr. Traner has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neuropace. Dr. Traner has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Ceribell Inc. Dr. Traner has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for National Resident Matching Program .
Adam J. Margolius, MD Dr. Margolius has nothing to disclose.
Umit Topaloglu No disclosure on file
Patricia Linortner, PhD No disclosure on file
Alexander Keenan Alexander Keenan has received personal compensation for serving as an employee of Janssen Pharmaceuticals. Alexander Keenan has received stock or an ownership interest from Johnson and Johnson.
Talora Martin, MD No disclosure on file
William H. Duong No disclosure on file
Hyeyoung Seol, MD Dr. Seol has nothing to disclose.
Brian Toh Brian Toh has nothing to disclose.